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ABSTRACT:
Oculodentodigital dysplasia (ODDD) is a rare developmental disease that results from 
any one of over sixty known autosomal-dominant or autosomal-recessive mutations in the 
gene GJA1, which encodes for connexin43 (Cx43). In the current study, we assessed the 
characteristic of six Cx43 mutants, including two autosomal-dominant mutants which have 
been associated with bladder defects (D3N and G143S), two autosomal-dominant mutants 
which have not been associated with bladder defects (G2V and I130T) and two autosomal- 
recessive mutants (R33X and R76H). Collectively, we revealed no differences in the 
molecular or Cx43 channel function of the bladder disease -associated or -unassociated 
mutants suggesting that bladder defects linked to ODDD may be associated with other 
factors such as aging and/or co-morbidities. We also found that the R76H mutant could form 
functional channels while the R33X was functionally dead. These studies provide molecular 
insights into how autosomal dominant or recessive mutations affect Cx43 channel function 
and how Cx43 function may be linked to disease severity.
Keywords: gap junctions, connexins, Cx43, autosomal-dominant, autosomal-recessive, 
bladder, mouse model of human disease, GJIC, ODDD, hemichannel
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The ability of cells to interact with their neighbours is an important cellular feature 
with implications in many processes from development to normal tissue function (Dahl et 
al. 1995, Rossello and Kohn 2010). One mechanism in which adjacent cells are able to 
interact is through gap junctional intercellular communication (GJIC). Almost every cell 
in the body expresses the protein(s) required for the production of gap junction channels. 
The presence of gap junction proteins enables cells of an organ to form a syncytium 
through GJIC, allowing the organ to function as a cohesive unit. This specialized form of 
communication is highly regulated and can be quickly altered depending on the cells 
physiological needs. Gap junction channels allow the movement of various cellular 
components; such as second messengers, ions, metabolites and nutrients, between 
connected cells (Alexander and Goldberg 2003, Veenstra 1996). Therefore, as a result of 
the ubiquitous use of GJIC, it may come as no surprise that an alteration in the ability of 
cells to directly communicate can produce a number of human diseases and pathologies 
(Cronier et al.. 2009).
1.2 Connexins
Vertebrate gap junctions are formed by specialized integral membrane proteins 
called connexins (Cxs) (Goodenough et al.. 1996). There are currently 21 human and 20 
mouse Cx isoforms which range from 23 to 62 kilo-Daltons (kD), whose names are 
largely based on the connexins molecular weight (Eiberger et al. 2001, Sohl and Willecke 
2003). Connexins are categorized based on sequence homology and cytoplasmic tail 
length (Berthoud et al. 2004). Each connexin member shares a similar topology,
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consisting of four transmembrane domains (TM 1 -  4), two extracellular loops (ELI and 
EL2), an intracellular loop (IL) and cytoplasmically exposed amino and carboxyl termini 
(Figure 1.1 A) (Maeda et al. 2009, Sohl and Willecke 2004).
Connexins are temporally and spacially regulated in human physiology. For 
example, keratinocytes are known to express Cx26, Cx30, Cx30.3, Cx31, Cx31.1 and 
Cx43, at different stages of differentiation (Salomon et al. 1994). On the other hand, 
some tissues continuously express only a few connexins. The liver, for example, is 
known only to expresses Cx26 and Cx32 (Paul 1986). The differential tissue expression 
of connexins suggests that the properties associated with each connexin are unique and 
specific to the cells expressing them.
1.3 Connexons, Hemichannels and Gap Junctional Plaques
Six connexins oligomerize within the Golgi apparatus to form a connexon (Figure 
1.1 B) which is delivered to the plasma membrane via transport vesicles (Lauf et al. 2002, 
Musil and Goodenough 1993). At the plasma membrane, the connexon may exist as a 
single undocked functional unit known as a hemichannel, or bind to a connexon from an 
adjacent cell to form a functional gap junction channel (Figure 1.1 C). In both cases, a 1.5 
nm pore is formed allowing for the selective passage of molecules generally less than 1 
kD in size (Alexander and Goldberg 2003, Veenstra 1996). Connexons and hemichannels 
were once thought to act exclusively as an intermediate step in gap junction channel 
formation (Li et al. 1996). More recent reports suggest that hemichannels, which are 
predominantly in a closed state, have the ability to open in response to mechanical stress,
metabolic stress and low extracellular calcium
4
Figure 1.1 Schematic representations of a connexin, hemichannels and gap junctions. Each 
connexin consists of four transmembrane domains (TM 1-4), two extracellular loops (ELI and 
EL2), an intracellular loop (IL) and cytoplasmically-exposed amino and carboxyl termini (A).
Six connexin proteins oligomerize to form a connexon which is delivered to the plasma 
membrane (B). Within the plasma membrane, connexons can either dock with a connexon from 
an adjacent cell forming a gap junction channel, or exist as a hemichannel (C). Tens to thousands 







(Jiang and Cherian 2003, John et al. 1999, Tong et al. 2007). The role of hemichannels in 
vivo has yet to be elucidated, although they are known to play a part in several cellular 
events including ATP release, intercellular calcium wave propagation and regulation of 
cell death (John et al. 1999, Kang et al. 2008, Plotkin et al. 2002, Spray et al. 2006, Stout 
et al. 2002).
When two connexons from apposing cells dock at sites of cell to cell apposition 
they form what is known as a gap junction channel (Figure 1.1 C) (Laird 1996, Musil and 
Goodenough 1990, Salameh 2006). Originally, electron microscopy revealed a 2-3 nm 
space between adjacent cells (Revel and Kamovsky 1967), but it is now known that this 
space consists of a few to thousands of gap junction channels that have coalesced into 
tightly packed gap junction plaques (Braun et al. 1984, Goodenough and Revel 1970). 
Once contained within a plaque, individual gap junction channels are capable of opening 
and allowing molecular passage. Gap junctions have a short half-life, relative to other 
proteins, varying from 1 -  5 hours depending on the tissue and connexin (Laird 2005). 
This quick turnover allows the cell to precisely control communication depending on it 
physiological needs.
1.4 Channel Diversity
The connexin composition of an individual gap junction channel is instrumental in 
creating channels with unique features (Veenstra 1996). As a result of co-expression of 
multiple connexin isoforms in the same cell type, gap junction channels can be formed 
through the co-oligomerization of different isoforms (Brink et al. 1997, Falk 2000).
However, not all connexin isoforms can co-oligomerize, allowing for further selectivity 
of the mixed connexin channels that can be assembled (Falk 2000). Ultimately, various 
hexameric combinations result in channel properties unique to the constituents of that gap 
junction channel (Cottrell and Burt 2005, Falk 2000, Valiunas et al. 2000). Connexons 
composed of one connexin isoform are termed homomeric; connexons composed of more 
than one connexin isoform are termed heteromeric. Further increasing the complexity and 
specificity of gap junction channels, the connexin composition of two docked connexons 
may be different. Homotypic channels are composed of identical connexons from 
apposing cells; whereas heterotypic channels are composed of two different connexons 
from apposing cells (Rackauskas et al. 2010).
1.5 Gap Junctional Function
Tens to thousands of gap junction channels coalesce into gap junction plaques at 
sites of cell to cell appositions (Goodenough and Revel 1970). The movement of a 
connexin within the plasma membrane is associated with its interaction with various 
proteins including microtubules and micro filaments (Laird 2010). The movement of a 
single Cx43-based gap junction channel into a gap junction plaque is associated with a 
change in the Cx43 phosphorylation state, allowing the channel to become functionally 
active (Musil and Goodenough 1991, Solan and Lampe 2007). The C-terminus of Cx43 
has many consensus sites for protein phosphorylation. Typically, Cx43 exists as three 
distinct species that are distinguished as P0, PI and P2, which is attributed to its increase 
states of phosphorylation (Solan and Lampe 2009). A reduction in the most
phosphorylated species (P2) has been shown to be associated with a reduction in GJIC 
(Koo et al. 1997).
Gap junction channels are not only regulated by phosphorylation, but also by 
cellular factors such as pH, voltage, and calcium, all of which affect channel function by 
regulating the extent by which the channel is either open or closed (Bukauskas and 
Weingart 1994, Peracchia and Wang 1997, Spray et al. 1984). For example, dual whole­
cell patch clamp has revealed that an alteration in the transjunctional voltage results in a 
voltage-dependent gating effect, a property that has been localized to the amino terminus 
of the connexin (Bukauskas and Peracchia 1997, Kyle et al. 2009). In addition, 
intracellular [H ] and [Ca ] are known to alter channel conductivity (Peracchia 2004). 
Intracellular pH is thought to regulate the interaction between the carboxyl terminus and 
channel forming amino acids, in a particle-receptor interaction (Morley et al. 1996).
Also, the intracellular loop of Cx43 contains a calmodulin binding motif, located at 
residues 136-158, which may play a role in how the channel is gated (Zhou et al. 2007).
1.6 Connexin Mutations and Disease
Mutations in genes encoding various connexins are known to cause at least eight 
distinct human diseases, which range in severity (Laird 2006). Several deafness and skin 
diseases have been associated with Cx26, Cx30, Cx30.1, Cx31 and Cx43 mutants (Laird 
2008, Lee and White 2009, Scott et al. 2011, White and Paul 1999), while mutations in 
the gene encoding Cx32 have been linked to X-linked Charcot-Marie Tooth disease, 




Figure 1.2 Composite of Cx43 mutations linked to ODDD. To date, over 60 mutations 
spanning the gene encoding Cx43 have been linked to ODDD. The majority of these mutations 
result in single amino acid substitutions (red balls), while two frame shift (grey balls), one 
deletion (orange ball) and two recessive mutants (purple balls) have also been linked to ODDD. 
ODDD mutants that have been reported to cause bladder impairments are denoted in yellow 
while select mutants that have not been linked to bladder conditions are noted in orange. The 
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Figure 1.2
Currently, over 60 mutations in the gene encoding Cx43 have been linked to 
oculodentodigital dysplasia (ODDD) (Figure 1.2) (Paznekas et al. 2009).
1.6.1 Oculodentodigital Dysplasia
Given that Cx43 is ubiquitously expressed, it is not surprising that loss-of-function 
Cx43 mutations affect development and several cellular functions. However, it is 
interesting to note that not all patients harbouring similar, or even the same mutation, 
have the same disease burden, suggesting that each patient’s genetic background also 
contributes to the severity of the disease. The common clinical characteristics associated 
with ODDD are syndactyly and camptodactyly of the digits, microdontia, enamel loss, 
ophthalmic defects and craniofacial abnormalities (Paznekas et al. 2009)1 Neurological 
defects, such as muscle weakness, seizures and bladder disturbances, are also frequently 
found in ODDD patients, although these symptoms are less common and normally do not 
manifest until later in the patient’s life (Loddenkemper et al. 2002).
The majority of mutations causing ODDD are single amino acid substitutions in the 
Cx43 protein, while other mutations such as frameshifts, deletions and truncations also 
exist (Figure 1.2) (Paznekas et al. 2009). A large number of these mutants maintain the 
ability to form gap junction-like structures; however, their functional characteristics are 
compromised (Gong et al. 2007, Lai et al. 2006, McLachlan et al. 2005, Roscoe et al. 
2005, Seki et al. 2004). Further studies have also reported that all Cx43 mutants tested 
acted as dominant-negatives to the gap junction channel function of co expressed wild- 
type Cx43 (Gong et al. 2007, McLachlan et al. 2005, Roscoe et al. 2005), suggesting that
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despite retaining one copy of wild-type Cx43, the gap junctional intercellular 
communication is likely severely reduced in ODDD patients.
Mutations associated with ODDD are generally autosomal-dominant; however, 
there have been a few reported autosomal-recessive cases, including the mutants R76H 
and R33X (Figure 1.2) (Paznekas et al. 2003, Pizzuti et al. 2004, Richardson et al. 2006). 
The current information on the R76H and R33X mutants and patients harbouring them is 
limited to genetic screening and a description of the patient’s health status (Pizzuti et al. 
2004, Richardson et al. 2006). Studies employing Cx43 knock-out mice have revealed 
that Cx43 is required for normal tissue development and survival, and that the loss of 
Cx43 is lethal at birth (Flenniken et al. 2005, Manias et al. 2008, Reaume et al. 1995,
Toth et al. 2010). In humans, the R33X autosomal recessive mutant in particular is 
effectively a Cx43 knockout as only 33 amino acids of Cx43 would be translated and no 
Cx43 channels would form. Patients harbouring the R33X mutant displays very severe 
clinical symptoms of ODDD (Richardson et al. 2006), and life expectancy is thought to 
be short. On the other hand, the R76H mutant may have residual gap junction channel 
function that could act to sustain life, although this has yet to be tested.
1.6.2 ODDD and Bladder Abnormalities
Along with the common clinical characteristics associated with ODDD, several less 
common syndromes have also been linked to Cx43 mutants. Neurological symptoms 
have been noted in ~30% of ODDD families, and these are known to progressively affect 
the lower half of the body (Loddenkemper et al. 2002, Paznekas et al. 2009).
Interestingly, incontinence has been reported in ~12% of 177 ODDD patients studied,
12
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although it should be noted that these symptoms generally do not present themselves until 
later in life (Paznekas et al. 2009). Therefore, it is possible that incontinence is a much 
larger problem and under-reported as many later life disease symptoms may not be 
archived as ODDD-associated diseases. Neurological symptoms have been proposed to 
be at the root of the majority of incontinence reports (Loddenkemper et al. 2002,
Paznekas et al. 2009); however, this has not been tested or investigated and myogenic 
defects may also exist in these patients. As a result of Cx43 expression throughout the 
different layers of the bladder (See 1.1.10) (Figure 1.3), it is thought that the resulting 
bladder abnormalities may also be the result of altered function in any one of the three 
layers associated with the bladder.
1.6.3 ODDD Mutant Mouse Models
To further study ODDD and the role of Cx43, several disease-linked Cx43 mutant 
mice have been generated. The present study used GJAlJrl/+ (Flenniken et al. 2005) and 
the GJA1i,30T/+ (Kalcheva et al. 2007) (referred to as the G60S and I130T mice 
respectively) heterozygous mutant mice that carry one copy of the Cx43 mutant and one 
copy of wild-type Cx43. As assessed in several distinct tissues, including heart, skin, 
ovary and teeth, both mice exhibit reduced Cx43 levels and Cx43 function (Flenniken et 
al. 2005, Kalcheva et al. 2007, Langlois et al. 2007, Toth et al. 2010). The mouse 
harbouring the G60S mutant was generated at the Centre for Modeling Human Diseases 
(Toronto, Canada), in a N-ethyl-N-nitrosourea mutagenesis screen. It was made available 
to the UWO Gap Junction Group by Dr. Janet Rossant. This mutation lies in the first 
extracellular domain, a domain known for its importance in connexon docking
14
1
Figure 1.3 Summary of the reported connexin expression in the bladder. Hematoxylin and 
eosin stained bladder sections revealed the urothelium, the lamina propria, and the detrusor 
layers of the bladder. Higher magnification images revealed that the urothelium is composed of 
transitional epithelium while the lamina propria is composed of loose fibroelastic connective 
tissue, and the detrusor is composed of smooth muscle cell bundles. Previous studies have 
reported that the urothelium expresses Cx26 and Cx43, the lamina propria expresses Cx43, while 




(Figure 1.2) (John and Revel 1991). While this mutation has yet to be reported in any 
human ODDD patients, the mice share phenotypic characteristics similar to ODDD 
patients. G60S mice exhibit syndactyly of the forelimb and hindlimb digits, craniofacial 
(including dental) abnormalities, ocular anomalies, cardiac disturbances and skeletal 
alterations (Flenniken et al. 2005). Subsequent in vitro studies have revealed that the 
G60S Cx43 mutant is frequently retained within the Golgi apparatus, but can escape and 
assemble into gap junction-like plaques at sites of cell to cell appositions; however, the 
channels formed are not functional and exhibit a dominant-negative effect on endogenous 
wild-type Cx43 (Flenniken et al. 2005, McLachlan et al. 2005).
The mouse harbouring the I DOT mutant was generated by Dr. Glenn Fishman 
(New York, USA), using a site-directed mutagenesis protocol. This mutation lies within 
the intracellular loop of Cx43, a region known for its importance in pH gating and 
calmodulin binding (Figure 1.2) (Peracchia and Wang 1997, Zhou et al. 2007). I130T 
mice exhibited several phenotypic characteristics similar to ODDD patients, such as 
syndactyly and slow cardiac conductance (Kalcheva et al. 2007). At the molecular level,
I DOT mice were shown to have a reduction in channel function in cultured myocytes, 
which was thought to arise as a result of a reduction in the higher phosphorylated Cx43 
species (PI and P2 -  see section 1.1.5) (Kalcheva et al. 2007). Subsequent in vitro studies 
have revealed that, similar to that seen in vivo, the I DOT mutant assembles into gap 
junction-like plaques at sites of cell to cell appositions; however, the channels formed 
have greatly reduced conductance compared to wild-type Cx43 (Lai et al. 2006, 
Shibayama et al. 2005).
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1.7 Bladder Structure and Function
The bladder is a hollow semicircular organ located in the pelvic region of the 
abdomen. Urine enters the bladder through two ureters, one extending from each kidney, 
that insert into the body of the bladder. Following bladder contractions, urine exits the 
bladder through the urethra, extending out of the base of the bladder. Histologically, the 
bladder is composed of three distinct layers; the urothelium, the lamina propria and the 
detrusor, each responsible for a specific function (Figure 1.3).
1.7.1 The Urothelium
The primary function of the urothelium was originally thought to be a passive 
barrier that prevents the entry of pathogens, but selectively controls the passage of water, 
ions and other molecules to the underlying tissue (Apodaca 2004). Composed of 
transitional epithelial tissue, the urothelium contains basal cells, intermediate cells and 
umbrella cells (Apodaca 2004, Birder and de Groat 2007). In order to maintain a passive 
barrier, urothelial cells are connected via tight junctions and contain a unique lipid- 
protein composition in the apical membrane of umbrella cells. (Lewis 2000). When the 
barrier is compromised, substances can pass into the underlying tissue causing urgency, 
frequency and pain (Birder 2001).
Recent studies have shown that the urothelium is more than just a passive barrier 
and actually plays an important role in sensing and responding to mechanical and 
chemical stimuli (Apodaca 2004, Birder and de Groat 2007, de Groat 2004). Several 
molecules are known to be released from the urothelium following physical or chemical 
stimulation, including ATP, NO, acetylcholine and cytokines. As well, receptors for
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many molecules, such as purines, norepinephrine, acetylcholine and Na+ are known to be 
expressed in the urothelium (Birder 2001). In particular, ATP release is thought to signal 
adjacent urothelial cells and/ or bladder nerves through P2X receptor stimulation within 
the underlying lamina propria; therefore, acting in both an autocrine and paracrine 
fashion (Apodaca 2004, Birder 2001, Cockayne et al. 2000)
1.7.2 The Lamina Propria
The lamina propria consists of loose fibroelastic connective tissue containing 
nerves, blood capillaries, a small amount of smooth muscle, and fibroblasts. There is a 
debate as to whether the fibroblasts are actually myofibroblasts or even interstitial cells, 
as seen in other tissues such as the stomach, prostate, liver and lungs (Schurch et al.
1998). Myofibroblasts contain features similar to both fibroblasts and smooth muscle 
cells (Wiseman et al. 2003). Their close proximity to afferent nerves and their ability to 
release and become activated by ATP suggest that these cells act as signal transducers 
within the bladder (Birder and de Groat 2007, Fry et al. 2007, McCloskey 2010, Wu et al. 
2004).
1.7.3 The Detrusor
The detrusor is composed of smooth muscle cells sequestered into separate muscle 
bundles rich in nerve innervations. This layer has the function of maintaining bladder 
shape during filling and to providing the driving force behind bladder voiding (Andersson 
1999, Kanai 2011). Shape is maintained via small tonic contractions of separate muscle 
bundles around the bladder. Voiding, however, is the result of a coordinated contraction
of the entire detrusor, made possible via the innervation of afferent and efferent nerves, 
the urothelium, and cells of the lamina propria (Kanai 2011, Neuhaus et al. 2005).
1.8 Bladder Abnormalities
The bladder functions as a storage and emptying vessel for urine. Disruption of 
either function may result in bladder disease or malfunction including incontinence, 
residual urine retention and pain (Christ et al. 2003). The most common type of bladder 
abnormality is detrusor overactivity, which is the result of an increase in smooth muscle 
contraction. However, the physiological mechanism that initiates this overactivity is not 
clearly understood (Christ et al. 2003). Controversy in this field surrounds the 
mechanistic origin of bladder overactivity and determination of whether or not the 
stimulus is of neuronal or myogenic origin (Christ et al. 2003, Haefliger et al. 2002). 
There are two main forms of incontinence: stress, which is the result of an increased 
abdominal pressure, and urge, which is involuntary leakage accompanied by, or 
immediately followed by, urgency. Urge can be further broken down into myogenic, 
thought to be of muscular origin, and neurological, thought to be of neuronal origin. 
(Christ et al. 2003). Although neurological defects are thought to represent the majority 
of abnormalities, there is a growing body of evidence to suggest a myogenic origin for at 
least some forms of incontinence (Haferkamp et al. 2004).
Bladder outlet obstructions (BOO), although not used in this study, are thought to 
be one of the best models for studying bladder abnormalities in vivo. In men, this 
condition usually arises as a result of benign prostatic hyperplasia, effectively reducing 
the diameter of the urethra (Miyazato et al. 2009, Mori et al. 2005). BOO models result in
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phenotypes similar to those reported in humans, such as increase urine retention, detrusor 
hypertrophy and spastic bladder contractions (Imamura et al. 2009, Miyazato et al. 2009, 
Mori et al. 2005). It is thought that altered coupling of smooth muscle cells may be the 
cause, resulting in increased sensitivity to acetylcholine, or changes in how cells 
communicate (Imamura et al. 2009).
1.9 Connexins in the Bladder and Their Response to Bladder Syndromes
Various connexins are known to be expressed within the bladder, although 
controversy exists as to where they are localized. Overall, Cx26, Cx40, Cx43, and Cx45 
have all been localized to some layer of the human bladder, using both 
immunohistochemistry and immunoblotting techniques (Haefliger et al. 2002, John et al. 
2003a).
1.9.1 The Urothelium
The majority of reports suggest that Cx26 is the primary connexin localized in the 
urothelium (Gee et al. 2003, Grossman et al. 1994, Haefliger et al. 2002, Ikeda et al. 
2007), although its function has yet to be elucidated. Cx26 is generally observed as 
punctate structures within the urothelium (Haefliger et al. 2002, Ikeda et al. 2007); 
however, one study has localized Cx26 to a more cytoplasmic profile in samples from 
bladder tumors (Gee et al. 2003). Several reports have indicated that Cx43 may also be 
localized to the urothelial layer in both humans and rats (Grossman et al. 1994, Haefliger 
et al. 2002); however, other reports have suggested that Cx43 is only localized to the
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lamina propria and detrusor layers (see sections 1.1.10.2 and 1.1.10.3, respectively) (Fry 
et al. 2007, Hashitani et al. 2004, Neuhaus et al. 2005, Sui et al. 2002, Wang et al. 2006).
Cx26 levels have been reported to increase as a result of bladder dilation (filling), 
followed by a reduction after voiding in rat models of bladder outlet obstruction 
(Haefliger et al. 2002). Therefore, Cx26 within the urothelium is thought to be important 
in bladder signaling and possibly in bladder malfunction through various mechanisms 
(Apodaca 2004, Birder and de Groat 2007, Imamura et al. 2009, Sui et al. 2002).
1.9.2 The Lamina Propria
Currently, Cx43 is the only connexin that has been localized to the lamina propria 
in both human and rat bladders (Fry et al. 2007, Neuhaus et al. 2005, Sui et al. 2002). 
Cx43 forms punctate structures at sites of cell to cell apposition throughout the lamina 
propria in vimentin-positive cells, indicative of fibroblasts (Neuhaus et al. 2007, Sui et al. 
2002). Flowever, others have suggested that these same cells may in fact be 
myofibroblasts (Fry et al. 2007, Sui et al. 2002, Wiseman et al. 2003), which share 
characteristics of both fibroblasts and smooth muscle cells (Hinz 2010). Cx43 has been 
proposed to form a functional syncytium within the lamina propria, aiding in bladder 
contraction during voiding (Neuhaus et al. 2005, Sui et al. 2002).
There have been no reports of Cx43 changing within the lamina propria following 
bladder outlet obstructions. However, it is nearly impossible to separate this layer from 
the surrounding urothelium and detrusor layers which may hinder quantification of Cx43 
levels in the lamina propria. It is still possible that an alteration in the amount of Cx43, or 
changes in Cx43 spatial localization, may be associated with some bladder malfunction.
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Interestingly, basic fibroblast growth factor (bFGF) has been shown to be released from 
the urothelium in bladder outlet obstruction models (Imamura et al. 2009). Therefore, 
bFGF, which is known to increase Cx43 expression (Doble and Kardami 1995), may 
affect the lamina propria, altering its connexin status, resulting in a bladder malfunction.
1.9.3 The Detrusor
Various studies have indicated that Cx40, Cx43 and Cx45 are the only connexins 
present in the detrusor layer of human and rat bladders, although they are differentially 
localized within this layer (Hashitani et al. 2004, John et al. 2003b, Sui et al. 2003, Wang 
et al. 2006). Cx40 is thought to reside in bladder vasculature (Hashitani et al. 2004, John 
et al. 2003b), and therefore may not play a role in bladder function. Cx43 is localized to 
the border of smooth muscle cell bundles, suggesting a role in the propagation of Ca 
wave and other chemical signals from one muscle bundle to another (Hashitani et al. 
2004, Wang et al. 2006). Conversely, Cx45 is localized to the plasma membrane of 
smooth muscle cells, within the muscle bundles (John et al. 2003b, Sui et al. 2003). Both 
findings suggest that these connexins work together to form a syncytium, allowing for 
uniform bladder contractions. Upon BOO this layer has been reported to exhibit the most 
significant change in connexin status. Detrusor-localized Cx43 has been shown to 
increase in all models of BOO, suggesting it is critically important in the normal function 




We hypothesized that both bladder disease -associated and -unassociated ODDD 
Cx43 mutants will disrupt gap junctional intercellular communication and hemichannel 
properties within reference cell lines. As well, the Cx43 localization and expression 
profile will be altered in the bladders of G60S and I DOT Cx43 mutant mice.
Chapter 3:
We hypothesized that ODDD-associated recessive Cx43 mutants (R33X and 
R76H) are loss-of-function mutants.
1.11 Objectives
Chapter 2:
1. Characterize the localization and function of bladder disease -associated (D3N 
and G143S) and -unassociated (G2V and I DOT) Cx43 mutants when expressed 
in reference cell models.
2. Determine the expression and distribution of Cx43 and Cx26 in the bladder of 
G60S and I DOT Cx43 mutant mice and their control littermates.
Chapter 3:
1. Characterize the localization and function of two recessive Cx43 mutants (R33X 
and R76H) when expressed in reference cell models.
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CHAPTER 2
Characteristics and Functions of Connexin43 Mutants linked to 
Oculodentodigital Dysplasia with Respect to Bladder Tissue
31
Oculodentodigital dysplasia (ODDD) is a rare developmental disease resulting 
from germ line mutations in the GJA1 gene, which encodes connexin43 (Cx43). Upon 
clinical examination, ODDD patients expressing the D3N and G143S mutants have 
reported impaired bladder function manifesting in some degree of incontinence. 
Conversely, ODDD patients harbouring topographically similar mutations, G2V and 
I130T, have yet to report any bladder impairments. Although the importance of Cx43 
expression in the bladder is poorly understood, it is hypothesized that Cx43 plays a 
critical role in normal bladder function. To investigate the characteristics of bladder 
disease -associated (D3N and G143S) and -unassociated (G2V and I130T) ODDD- 
linked Cx43 mutants we first expressed the Cx43 mutants in connexin-positive NRK or 
connexin-negative HeLa cells. Immunofluorescence revealed that all mutants contained 
the ability to form gap junction-like plaques. However, micro injection of Lucifer yellow 
dye into mutant-expressing cells resulted in only a few incidents of dye transfer, 
suggesting that all Cx43 mutants failed to form functional gap junctions, and were also 
dominant-negative to the function of endogenous Cx43. In addition, in an ATP release 
assay, we noted that the G2V and D3N mutants exhibited more hemichannel activity in 
HeLa cells than the I130T or G143S mutants and wild-type Cx43, but none of the 
mutants altered ATP release in NRK cells. To assess the impact of Cx43 mutants on 
bladder histology and connexin distribution in vivo, we employed two heterozygous 
mutant mouse lines that express the G60S or I130T Cx43 mutants. The overall 
localization pattern of Cx43 in the lamina propria and detrusor appeared to be unaltered 
in bladder tissue of I130T and G60S mice, but the distribution pattern was more
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intracellular in bladder tissue from the G60S mice. Both mutant mice exhibited a 
significant reduction in the highly phosphorylated PI and P2 iso forms of Cx43. 
Interestingly, Cx26 exhibited an intracellular localization profile that was restricted to the 
basal cells of the urothelium in all mice suggesting that Cx26 may play a role in 
urothelial signaling. Our studies suggest that the reason only some ODDD patients have 
bladder defects is not rooted in clear differences in Cx43 mutant localization, channel or 
hemichannel function. Thus, either the molecular changes caused by specific Cx43 
mutations have yet to be uncovered or any ODDD patient may be susceptible to 
developing bladder defects during aging or depending on the existence of other co­
morbidities.
Keywords: Connexin, Cx43, mutants, bladder, mouse model of human disease, 
hemichannel, GJIC, ODDD
33
Overactive bladder (OAB) is a syndrome that affects millions of men and women 
worldwide, generally manifesting itself in some degree of incontinence. In the United 
States alone, OAB is known to affect approximately 17% of the population (Abrams et al. 
2003), with an estimated economic cost of 12.6 billion dollars (Hu et al. 2004). The 
current consensus is that there are two main forms of incontinence: stress and urge. Stress 
incontinence is caused by increased intra-abdominal pressure, resulting from physical 
activity or coughing/sneezing. The second form, urge, can be subdivided into neurogenic 
or idiopathic. Neurogenic is related to altered afferent and efferent neuronal bladder 
stimuli, which is common in conditions such as spinal cord injury, Parkinson’s disease 
and multiple sclerosis (Christ et al. 2003). Idiopathic is associated with incontinence in 
which no pathological causation is known (Christ et al. 2003, Miller and Hoffman 2006). 
However, there is a growing body of evidence to suggest a myogenic origin for at least 
some forms of idiopathic incontinence (Brading 1997, Haferkamp et al. 2004). It has 
been proposed that altered gap junctional intercellular communication (GJIC) or cell 
signaling may be the cause of idiopathic incontinence, resulting in an increased 
sensitivity to acetylcholine, or changes in how cells communicate (Imamura et al. 2009, 
Kuhn et al. 2008a).
GJIC is an important cellular feature that allows cells to communicate with their 
neighbours, and has been implicated in a number of processes from tissue development to 
normal tissue function (Dahl et al. 1995, Rossello and Kohn 2010). Gap junctions are 
formed from specialized proteins known as connexins (Cxs). Six connexins that have 
oligomerized to form a connexon are delivered to the plasma membrane where they can
2.1 Introduction
function as hemichannels or dock to a connexon from an adjacent cell forming a gap 
junction channel (Goodenough et al. 1996). Both active hemichannels and gap junction 
channels can selectively pass small molecules of less than 1 kD in size to the extracellular 
matrix or between connected cytoplasms, respectively (Alexander and Goldberg 2003, Li 
et al. 1996, Musil and Goodenough 1990). The selectivity of a gap junction channel or 
hemichannel is highly dependent on its connexin constituents. The 21 human and 20 
mouse connexins all share similar membrane topologies and can selectively intermix to 
create a plethora of channel variations that exhibit unique characteristics (Eiberger et al. 
2001, Maeda et al. 2009). Cx26, Cx40, Cx43 and Cx45 have all been reported to be 
expressed in one or more layers of the bladder (Haefliger et al. 2002, John et al. 2003a). 
Cx43, the most ubiquitously expressed connexin in the body, has been localized 
throughout the various layers of the bladder and is thought to mediate function.
In the bladder, the urothelial layer is composed of transitional epithelium which 
acts as a passive barrier and actively responds to urine composition and bladder 
distension (Apodaca 2004, Birder and de Groat 2007, de Groat 2004). ATP, known to be 
released from the urothelium, is thought to signal adjacent urothelial cells and/or bladder 
nerves through P2X receptor stimulation within the underlying lamina propria, therefore, 
acting in both an autocrine and paracrine fashion (Apodaca 2004, Birder 2001, Cockayne 
et al. 2000). Both Cx26 and Cx43 have been localized to the urothelium, although their 
roles in bladder function have yet to be elucidated (Grossman et al. 1994, Haefliger et al. 
2002). The lamina propria, composed of loose fibroelastic connective tissue, expresses 
Cx43 which is localized to fibroblasts and myofibroblasts (Fry et al. 2007, Neuhaus et al. 
2007, Sui et al. 2002, Wiseman et al. 2003). Myofibroblasts have been shown to be in
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close proximity with both afferent and efferent neurons and are therefore thought to aid in 
bladder signaling (Sui et al. 2002, Wiseman et al. 2003). The detrusor layer of the bladder 
is composed of smooth muscle cells that express both Cx43 and Cx45 which collectively 
act to facilitate bladder contractions (Andersson 1999, Kanai 2011). Specifically, Cx43 
has been localized to the border of smooth muscle cell bundles suggesting its importance 
in the transmission of electrical stimulus from one muscle bundle to the next, while Cx45 
has been localized to the plasma membrane of cells within the muscle bundles (Hashitani 
et al. 2004, John et al. 2003b, Sui et al. 2003, Wang et al. 2006).
To date, over 60 mutations in the gene encoding Cx43 have been linked to the 
rare autosomal dominant disease oculodentodigital dysplasia (ODDD) (Paznekas et al. 
2009). All mutants examined to date have been shown to have reduced channel function, 
and also act as dominant-negatives to the function of co-expressed wild-type Cx43 (Gong 
et al. 2007, McLachlan et al. 2005, Roscoe et al. 2005). Patients harbouring Cx43 
mutants share common clinical characteristics, such as syndactyly and camptodactyly of 
the digit, microdontia, enamel loss, ophthalmic defects and craniofacial abnormalities 
(Paznekas et al. 2003). Bladder disturbances have been reported in ~12% of ODDD 
patients although the mechanism behind bladder defects remains poorly understood 
(Loddenkemper et al. 2002, Paznekas et al. 2009). Although, the percentage of ODDD 
patients suffering from bladder defects is lower than the general population at ~17% 
(Abrams et al. 2003), many of these patient develop bladder defect early in their life 
(Paznekas et al. 2009) a trait rarely seen in the general population. Since Cx43 is broadly 
distributed throughout the bladder and is thought to play a critical role in bladder 
contraction we suggested that the reason ODDD patients may suffer from bladder
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problems may be rooted in how specific ODDD-linked mutants affect the distribution and 
function of Cx43-based gap junctions within the bladder.
To further study the physiological role(s) of Cx43 two heterozygous Cx43 mutant 
mouse lines harbouring the G60S or I130T mutants were generated and shown to mimic 
ODDD (Flenniken et al. 2005, Kalcheva et al. 2007). Upon examination of several cell 
types obtained from these mice, all were found to exhibit reduced Cx43-based GJIC and 
the mutant proteins were found to act as dominant-negatives to co-expressed wild-type 
Cx43 (Flenniken et al. 2005, Kalcheva et al. 2007, Lai et al. 2006, Manias et al. 2008, 
McLachlan et al. 2005, Shibayama et al. 2005). However, the status of Cx43 in the 
bladder of these mutant mice has not been examined.
In the present study, Cx43 mutants (D3N and G143S) that have been linked to 
incontinence and mutants (G2V and I130T) that have not been associated with 
incontinence were characterized. The G2V and D3N mutations are localized to the Cx43 
amino-terminus, a region known to act as a transjunctional voltage sensor (Bukauskas 
and Peracchia 1997), while the I130T and G143S mutations are localized to the 
intracellular loop region, an important domain in pH gating and calmodulin binding 
(Peracchia 2004, Zhou et al. 2007). In addition, we examined the distribution and spatial 
localization of Cx43 in the bladders of two Cx43 mutant mouse lines to assess if Cx43 
was perturbed in a manner that might suggest the bladder is functionally compromised.
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2.2.1 Cell Culture
All cell culture reagents and labware were purchased from Invitrogen (Burlington, 
ON), and Becton-Dickenson (BD, Franklin Lakes, NJ). Human cervical cancer (HeLa) 
and normal rat kidney (NRK) cells, purchased from American Type Culture Collection 
(ATCC), were cultured in Dulbecco’s Modified Essential Medium (DMEM) 4.5 g/L D- 
glucose supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 pg/ml 
streptomycin and 2 mM L-glutamine at 37°C and 5.0% CO2. Prior to reaching 
confluency, cells were passed by enzymatic dissociation with 0.25% trypsin/EDTA 
solution at 37°C for 5-15 minutes.
2.2.2 Generation of Untagged and GFP-tagged Cx43 Mutants (G2V, D3N, G143S,
I130T)
Human untagged and/or GFP-tagged G2V, D3N, G143S cDNA constructs were 
purchased from Norclone Biotech Industries (London, ON). I130T and G143S cDNA 
constructs were synthesized in-house using a QuikChange Multi Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA) and sequenced for verification. Primer 
sequences used for I130T and G143S mutants are: I130T-forward 5’-gacatgcacttgaagcaga 
ctgagataaagaagttcaag-3 ’, 113 0T-reverse 5 ’ -cttgaacttctttatctcagtctgcttcaagtgcatgtc-3 ’, 





Transient transfection of cells was performed using a Lipofectamine 2000 reagent 
(Invitrogen) as recommended by the manufacturer and as previously described (Roscoe et 
al. 2005). Briefly, HeLa and NRK cells were grown to 50-70% confluency in 60 mm 
culture dishes. In cases where cells were used in the ATP release assay, HeLa and NRK 
cells were seeded in 12 well culture plates at 200,000 cells/well and 90,000 cells/well, 
respectively, one day prior to transfection. Transfection mixtures were prepared using 
OptiMEM (Invitrogen) with 5 pg of plasmid cDNAs and 2 pL of Lipofectamine 2000 
reagent. Untagged plasmid cDNA was co-transfected with 1 pg DsRed plasmid cDNA. 
The transfection mixture was gently mixed and allowed to sit at room temperature for 15 
minutes. The transfection mixture was then added to OptiMEM washed cells and 
incubated at 37°C for 5 hours. Finally, the transfection medium was removed, replaced 
with regular DMEM culture medium and the cells were incubated for another 24-48 
hours.
2.2.4 Immunocytochemistry
Transfected cells were fixed and immunolabeled as previously described (Roscoe 
et al. 2005). Briefly, cells grown on 12 mm glass coverslips were fixed with precooled - 
20°C, 80% methanol -20% acetone mixture for 15 minutes at 4°C followed by several 
rinses with phosphate-buffered saline (PBS). Cells were then blocked with 3% bovine 
serum albumin (BSA) (Sigma-Aldrich, St Louis, MO) and 0.02% Triton-XlOO in PBS for 
45 minutes at room temperature. Cells were incubated with polyclonal rabbit anti-Cx43 
primary antibody (2 pg/ml; Sigma C6219) for 1 hour at room temperature. After repeated
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washing with PBS, cells were incubated with anti-rabbit AlexaFluor 555 (4pg/ml; 
Invitrogen A-21429) for 1 hour at room temperature. Nuclear staining was performed 
using Hoechst 33342 (10 pg/ml; Molecular Probes, Eugene, OR H3570) for 5 minutes at 
room temperature, followed by a 5 minute wash with ddFEO. Coverslips were mounted 
on glass slides and allowed to sit overnight at 4°C. Labelled cells were imaged on a Zeiss 
LSM 510 Meta confocal microscope as previously described (Roscoe et al. 2005). Digital 
images were prepared using Zeiss LSM and CorelDraw 12 software.
2.2.5 Microinjection Dye Transfer Assay
Culture dishes, 60 mm, containing HeLa or NRK cells transiently transfected with 
cDNA encoding untagged or GFP-tagged Cx43, G2V, D3N, I130T or G143S were 
selected for microinjection. For GFP expressing mutants, cell clusters expressing GFP at 
sites of cell to cell appositions were selected for microinjection. For untagged mutants, 
cell clusters expressing DsRed in two adjacent cells were selected for microinjection. 
Single cells within transfected clusters were pressure injected using an Eppendorf 
Femtojet automated pressure microinjector with 2.5% Lucifer yellow dye (Invitrogen) 
until the cell brightly fluoresced. Three minutes after injection, digital images were 
collected using a Lecia DM IRE2 inverted epifluorescence microscope with a charged 
coupled camera (Hamamstsu Photonics, Japan) using OpenLab software. Dye transfer 
was recorded as being positive if the injected cell passed dye to a contacting cell 
expressing either GFP or RFP. Both untransfected Cx43-negative HeLa cells and Cx43- 
positive NRK were included for all studies. At least 80 microinjections were preformed 
for each mutant tested on 5 to 6 separate transfections.
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2.2.6 ATP Release Assay
Culture plates (12 well plates containing one coverslip per well) containing HeLa 
or NRK cells transiently transfected with cDNA encoding untagged or GFP-tagged Cx43, 
G2V, D3N, I130T or G143S were selected. Transfection efficiency for all mutants was 
-40-60% (data not shown). The ATP release assay was carried out as described 
previously (Tong et al. 2007), with the following changes. Briefly, for control conditions, 
all cells were washed twice with normal HBSS (Invitrogen) containing calcium and 
magnesium. For calcium-free conditions, cells were washed once with normal HBSS 
followed by a second wash with divalent-cation-free (DCF)-HBSS (Ca2+ and Mg2+ were 
replaced by 2 mM EGTA). Cells were then incubated in 500 pL of either normal HBSS 
or DCF-HBSS for 15 minutes at 37 °C. Following incubation, 10 pL of the incubation 
solution was removed and mixed with 90 pL of the reaction solution corresponding to the 
ATP Determination Kit (Invitrogen) instructions. ATP concentration was determined by 
measuring bioluminescence (at a wavelength of -560 nm) with a luminometer 
(PerkinElmer, Waltham MA). Coverslips containing transfected cells were then fixed, 
labeled and imaged for Cx43 as mentioned in section 2.2.4. Four images per transfection 
were taken, after which images were assessed by a blind observer and the percent 
transfection efficiency was determined.
2.2.7 Animals
Animal studies were conducted on two mutant mouse lines harbouring either the 
G60S or I130T Cx43 mutants. Importantly, both mice are heterozygous for the gene
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Gjal, which encodes Cx43. Therefore, the mice are expected to translate a 1:1 ratio of 
mutant to wild-type Cx43 protein and, thus genetically match human ODDD patients
G60S, also known as GjalJrt/+, mice were supplied by the Centre for Modeling 
Human Disease, University of Toronto, on a mixed C57BL/6J and C3H/HeJ background 
(Flenniken et al. 2005). After confirming 100% penetrance of the syndactyly feature by 
PCR genotyping (Flenniken et al. 2005), subsequent genotypes determination was 
completed using visual inspection of pups. The mice were maintained under a constant 
photo period of 12 h light:dark cycle and received food and water ad libitum.
The I130T, also known as GjalII30T/+, mice were obtained from Dr. Glen 
Fishman, New York University School of Medicine, New York. These mice, which were 
on a mixed CD1/C57BL6 background, were further backcrossed onto a C57BL6 
background for an additional 1-3 generations. A 100% incidence rate of syndactyly (n= 
203) in the I DOT mice was confirmed by PCR genotyping. However, while syndactyly 
was found on the front limbs of all mice, the back limbs did not always exhibit this 
phenotype.
2.2.8 Tissue Harvesting and Preparation
Whole bladder, heart and liver samples were collected from G60S, I DOT and 
wild-type littermate mice at 3 months postnatal. All mice used in this study were 
euthanized using a carbon dioxide chamber followed by cervical dislocation, in 
accordance with the University of Western Ontario Guide for Care and Use of Laboratory 
Animals. Tissue samples assigned to hematoxylin and eosin staining were fixed overnight 
at 4°C in 10% neutral buffered formalin (NFB) (EMD, Mississauga, ON), dehydrated,
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embedded in paraffin blocks, and sectioned longitudinally at 5pm intervals. Tissue 
samples assigned to immunohistochemistry were snap frozen in liquid nitrogen, 
embedded in a 10.24% polyvinyl alcohol, 4.26% polyethylene glycol Optimal Cutting 
Temperature Compound (Sakura, Torrance, CA), sectioned longitudinally at 5 pm 
thickness, and stored at -80°C. Tissue samples assigned to immunoblotting were snap 
frozen in liquid nitrogen and stored at -80°C for future use.
2.2.9 Histology
To assess the histology of the mouse bladders, 5 pm paraffin-embedded sections 
from G60S and I130T mice and their wild-type littermates were stained with hematoxylin 
(0.4%) and eosin (0.5%). Briefly, paraffin-embedded bladder sections were 
deparaffinised in xylene, rehydrated in a descending gradient of ethanol baths and stained 
with hematoxylin (5 minutes), washed and stained with eosin (5 minutes). Sections were 
then dehydrated in an ascending gradient of ethanol baths followed by xylene and 
mounted with Cytoseal (Thermo Scientific, Rockford, IL). Bladder sections were imaged 
on a Lecia DM IRE2 inverted microscope equipped with a Micropublisher 5.0 RTV CCD 
colour, cooled camera. Linear measurements were made perpendicularly through the 
detrusor layer using ImageJ software. In total, 405 measurements were made on each of 
four bladders from G60S and I130T mice and their wild-type littermates, corresponding 
to 3 slides per mouse, 9 sections per slide and 15 measurements per sections. Statistical 




To assess the localization of Cx43 and Cx26 in mouse bladders, hearts, and livers, 
5 (am cryo-sections from G60S and I DOT mice and their wild-type littermates were first 
fixed in 10% NBF for 30 minutes at room temperature. Tissues sections were blocked 
with 3% BSA (Sigma-Aldrich) and 0.02% Triton-XlOO in PBS for 45 minutes at room 
temperature. Cx43, Cx26 and actin were all detected using: rabbit anti-Cx43 (2 pg/ml; 
Sigma C6219), rabbit anti-Cx26 (0.5 pg/ml; Invitrogen 51-2800) and mouse anti- 
phalloidin (2 U/ml; Invitrogen A12379) respectively. All antibodies were diluted in 3% 
BSA and 0.02% Tween-20 and allowed to incubate on tissue sections for one hour. After 
repeated washings with PBS, tissues were incubated with secondary anti-rabbit 
AlexaFluor 555 antibody (4 pg/ml; Invitrogen A-21428), followed by repeated washings. 
Nuclear staining was performed using Hoechst 33342 (10 pg/ml; Molecular Probes) for 5 
minutes at room temperature, followed by a 5 minute wash with ddF^C). Tissues sections 
were mounted using glass coverslips and allowed to sit overnight at 4°C. Tissue sections 
were imaged on a Zeiss LSM 510 Meta confocal microscope as previously described 
(Roscoe et al. 2005). Digital images were prepared using Zeiss LSM and CorelDraw 12 
software.
2.2.11 Western Blot Analysis
Tissue samples stored at -80°C were homogenized in Radio Immuno Precipitation 
Assay (RIPA) lysis buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1.0% Triton X- 
100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mN sodium orthovanadate, 1 mM sodium
44
fluoride), rocked for 1 hour at 4°C, and homogenates were removed from cell debris via a 
10 minute, 6000 rpm centrifugation at 4°C.
Immunoblotting was preformed as previously described (Gehi et al. 2011) using 
10 or 12% SDS-PAGE. Cx43, Cx26 and GAPDH were detected using polyclonal rabbit 
anti-Cx43 (0.02 pg/ml; Sigma C6219), polyclonal rabbit anti-Cx26 (0.05 pg/ml; 
Invitrogen 710500) and polyclonal mouse anti-GAPDH (1 pg/ml; Millipore, Temecula, 
CA), respectively. Primary antibodies were detected using either anti-rabbit AlexaFluor 
680 (0.2 pg/ml, Invitrogen) or anti-mouse IRDye 800 (1:10000; Rockland, Gilbertsville, 
PA) antibodies. Membranes were developed using an Odyssey infrared imaging system 
(LiCor, Lincoln, NE) and analyzed under unsaturated conditions using Odyssey 2.0.4 
software (Licor).
2.2.12 Statistics
All results were analyzed using the Student’s two-tailed independent sample t- 
test, using a P<0.05 value to denote significance. All results were analyzed using 
GraphPad Prism 4.03 software, are presented as mean ± standard error.
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2.3 Results
2.3.1 Cx43 mutants localize to sites of cell to cell apposition in HeLa and NRK cells
Cx43-negative HeLa cells and Cx43-positive NRK cells were transiently 
transfected with cDNA constructs encoding wild-type or mutant Cx43. 
Immunofluorescence revealed that GFP-tagged and untagged wild-type Cx43 assembles 
into gap junction-like plaque structures at sites of cell to cell apposition. As well, bladder 
disease -associated (D3N and G143S) and -unassociated (G2V and I130T) Cx43 mutants 
all assembled into gap junction-like plaques at sites of cell to cell apposition in both 
HeLa (Figure 2.1A,B) and NRK (Figure 2.2) cells. These localization patterns revealed 
that both sets of Cx43 mutants have the ability to make gap junctions when untagged or 
tagged with GFP.
2.3.2 Gap junction channels formed by Cx43 mutants are impermeable to Lucifer
yellow
To assess if Cx43 mutants could form functional channels in gap junctional 
intercellular communication (GJIC)-deficient HeLa cells, mutant-expressing cells were 
microinjected with Lucifer yellow that has the capacity to transfer through gap junctions. 
As a control, the expression of Cx43-GFP was found to greatly increase (by -85%) the 
incidence of dye transfer between microinjected HeLa cells (Figure 2.3A), as opposed to 
untransfected HeLa cells. However, the expression of bladder disease -associated and -  
unassociated Cx43 mutants resulted in only a few incidences of dye transfer (—6-18%) 
similar to that of untransfected HeLa cells (Figure 2.3A), suggesting that both sets of 
Cx43 mutants were not competent in assembling into functional gap junction channels.
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Figure 2.1 Cx43 mutants localized to sites of cell to cell appositions in HeLa cells. HeLa cells 
were transfected with cDNA encoding GFP-tagged (A) and untagged (B) Cx43, G2V, D3N, 
I130T or G143S. Mutants assembled into gap junction plaques (arrowheads) at sites of cell-cell 
appositions in HeLa cells. Cells were immunolabeled for Cx43 (Red). Green = GFP, Blue = 
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Figure 2.1
Figure 2.3 Cx43 mutants localize to sites of cell to cell appositions in Cx43-positive NRK 
cells. NRK cells were transfected with cDNA encoding GFP-tagged Cx43, G2V, D3N, I130T or 
G143S mutants. Cx43 mutants assembled into gap junction plaques (arrowheads) at sites of cell­
cell apposition and appeared to co-oligomerize with endogenous Cx43 (yellow). Cells were 
immunolabeled for Cx43 (red). Green = GFP, Blue = Hoechst nuclear stain. Bar = 20 pm
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Figure 2.3 Cx43 mutants form functionally compromised channels and act as dominant- 
negatives to the channel function of co-expressed endogenous Cx43. HeLa and NRK cells 
expressing Cx43 mutant proteins were subjected to microinjection with Lucifer yellow and 
assessed for dye transfer. Microinjected HeLa cells expressing wild-type Cx43 most often 
transferred dye while cells expressing any of the mutants rarely passed dye (A). NRK cells 
expressing wild-type Cx43 also had a significant increase in the percent incidences of dye 
transfer. However, the Cx43 mutant proteins acted as dominant-negatives to the channel function 
of co-expressed wild-type Cx43 significantly reducing the incidence of dye transfer in NRK cells 
(B). A. Bars represent means ± s.e.m.; * P<0.05, N = 5-6 replicate transfections. B. Bars with 
different superscript letters are significantly different (P<0.05)
Figure 2.3
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2.3.3 Cx43 mutants act as dominant-negatives on the channel function of co­
expressed endogenous Cx43
The ability of Cx43 mutants to affect the function of endogenous Cx43 was 
assessed by microinjecting Lucifer yellow dye into Cx43-positive NRK cell that co­
express the bladder disease -associated and -unassociated Cx43 mutants. As a control, 
and as expected, the expression of Cx43-GFP in NRK cells resulted in only a slight 
increase in dye transfer (by -12%) as the NRK cells were already highly coupled (Figure 
2.3B). However, all Cx43 mutants decreased the incidence of dye transfer by -41-73% 
(Figure 2.3B). Therefore, bladder disease -associated and -unassociated Cx43 mutants 
exhibit a dominant-negative effect on the channel function of co-expressed wild-type 
Cx43 in NRK cells.
2.3.4 The untagged Cx43 mutants, G2V and D3N, facilitate ATP release in Cx43-
negative HeLa cells
ATP release within the bladder is thought to be important in bladder signaling, 
and it has been shown that Cx43 hemichannels have the ability to release ATP (Apodaca 
2004, Birder 2001, Kang et al. 2008). Therefore, in order to assess whether Cx43 mutants 
were acting to alter ATP release, a low calcium-induced hemichannel ATP release assay 
was performed in HeLa cells. Transfection of cells resulted in an increase in ATP release 
when calcium levels were low, as opposed to at normal culture levels (Figure 2.4A-D). 
For GFP-tagged Cx43 mutants, ATP release was similar between both bladder disease -  
associated and -unassociated mutants compared to wild-type Cx43-expressing and 
untransfected HeLa cells (Figure 2.4A). However, it appeared as though the G2V-GFP
Figure 2.4 Cx43 mutants differentially affect ATP release depending on endogenous 
connexin status. HeLa and NRK cells transfected with cDNA encoding GFP-tagged or untagged 
Cx43, G2V, D3N, I DOT or G143S were treated with HBSS with calcium (+Ca2+) or without 
calcium (-Ca ) and assessed for extracellular ATP release. HeLa cells expressing GFP-tagged 
Cx43 mutants released similar levels of extracellular ATP concentrations as untransfected cells 
(A), whereas untagged G2V and D3N resulted in an increase in extracellular ATP concentrations 
compared to untransfected cells (B). However, when co-expressed with wild-type Cx43 all GFP- 
tagged and untagged Cx43 mutants resulted in similar extracellular ATP concentrations as 












mutant was trending towards a marked increase (Figure 2.4A). Both untagged amino 
terminal Cx43 mutants, G2V and D3N, resulted in a significant increase in the amounts 
of ATP released compared to both untransfected HeLa cells and wild-type Cx43. In 
contrast, the I130T and G143S mutants did not facilitate ATP release (Figure 2.4B).
To determine if Cx43 mutants altered the ATP release capacity of co-expressed 
endogenous Cx43, the mutants were expressed in Cx43-positive NRK cells (Figure 
2.4C,D). HeLa cells, which represented a negative control, exhibited little ATP release 
compared to untransfected NRK cells. However, all GFP-tagged (Figure 2.4C) and 
untagged (Figure 2.4D) Cx43 mutants yielded similar levels of ATP release compared to 
untransfected NRK cells. These results suggest that all Cx43 mutants do not affect the 
overall capacity of NRK cells to release ATP.
2.3.5 G60S and I130T bladders have similar histology and detrusor thickness as
wild-type littermates
Increased detrusor thickness is a known indicator of overactive bladder (OAB) 
syndrome, a type of bladder defect commonly seen in patients suffering from bladder 
abnormalities (Miyazato et al. 2009, Uvelius et al. 1984). Hematoxylin and eosin staining 
revealed that the G60S and I DOT mice display similar bladder histology as seen in their 
wild-type littermates, with no disruption in any of the three bladders layers (Figure 
2.5A,B). Subsequent detrusor measurements revealed that detrusor thickness was similar 
in the G60S and I DOT mice and their wild-type littermates.
Figure 2.5 G60S and I130T mouse bladders have similar histology and detrusor thickness 
as their wild-type littermate controls. Paraffin embedded bladders were sectioned, stained with 
H&E and measured for detrusor thickness. In all mice, the bladder structure was similar (A, B). 
Subsequent detrusor measurements revealed that G60S and I130T mouse bladders have similar 
thicknesses as wild-type littermates (C). Bar = 200 pm (A, B). Bars represent means ± s.e.m (C).







2.3.6 G60S and I130T bladders have reduced levels of the highly phosphorylated
Cx43 species
Previous studies have indicated that the total Cx43 levels and the levels of highly 
phosphorylated Cx43 species are reduced in various tissues of the G60S mouse 
(Flenniken et al. 2005, Manias et al. 2008, Tong et al. 2009, Toth et al. 2010), while 
much less is known about the Cx43 species status in I130T mice. Western blots were 
used to assess the levels and phosphorylation status of Cx43 in the mutant mouse 
bladders. As controls, Cx43 was detected in heart lysates, while absent in liver lysates 
from wild-type mice. The abundance of Cx43 within the heart required the sample to be 
loaded at very low concentration, resulting in an absence of detectable GAPDH. 
Immunoblotting for Cx43 in lysates from G60S and I130T mice and their wild-type 
littermates revealed low levels of Cx43 in the bladder samples of all mice (Figure 2.6A). 
Densitometry analysis revealed that total Cx43 levels were reduced in I130T mice, while 
levels remained similar in the G60S mice when compared to their wild-type littermates 
(Figure 2.6B,D). Cx43 generally resolves in SDS-PAGE as multiple bands, representing 
different phosphorylated species (P0, PI and P2). Further analysis revealed that the 
slower migrating Cx43 species, representing the P1 and P2 species, are reduced in both 
the G60S and I130T mice compared to their wild-type littermates (Figure 2.6C,E). These 
phosphorylated Cx43 species have previously been correlated with fully assembled gap 
junction plaques and channel function. Immunoblotting also revealed non-specific bands 
at -47-50 kD and -30 kD, in lysates from all bladder samples. Although these bands 
were present in only the bladder samples, it is unclear as to what these band represents 
and therefore they was not included in the densitometry analysis.
Figure 2.6 G60S and I130T mouse bladders exhibit a reduction in the phosphorylated
species of Cx43. Cx43 normally resolves as a triplet banding pattern representing different 
phosphorylated species of Cx43 (PO, PI, and P2), as seen in heart tissue (A). G60S, I130Tand 
wild-type littermate mouse bladders were all positive for Cx43 expression (A). Total Cx43 (PO, 
PI and P2) expression was reduced in I130T mouse bladders (B), while remaining similar in the 
G60S mouse bladders (D) as compared to their wild-type littermates. The higher phosphorylated 
Cx43 species (PI and P2) were reduced in the I130T (C) and G60S (E) mouse bladders 
compared to wild-type littermates. Non-specific bands were noted at -37-50 kD and -30 kD. 
Bars represent means ± s.e.m (B-E). * = (P<0.05). N = 5 (I DOT) and 6 (G60S)
Figure 2.6
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2.3.7 G60S mouse bladders have altered Cx43 distribution in the lamina propria
and detrusor layers
As a result of the altered Cx43 expression profile seen in G60S and I130T mice, it 
was postulated that Cx43 localization and/or distribution may be disrupted. As a positive 
control, Cx43 was clearly detected in the intercalated discs between adjacent 
cardiomyocytes (not shown). Immunofluorescence revealed that Cx43 was highly 
expressed in the lamina propria of the G60S and I DOT mice, similar to their wild-type 
littermates (Figure 2.7A,B). The Cx43 distribution at sites of cell to cell apposition in the 
I DOT mice appeared similar to that found in wild-type littermates (Figure 2.7B). 
However, the G60S mice exhibited a more diffuse intracellular Cx43 distribution pattern 
that was not clearly detected in wild-type littermates. Immunofluorescence also revealed 
that Cx43 was localized to the fibroblasts surrounding smooth muscle bundles in the 
detrusor layer (Figure 2.8A,B) of both mutant mice and their wild-type littermates.
2.3.8 G60S and I130T bladders have similar Cx26 levels as wild-type littermates
The bladder urothelium has previously been shown to express Cx26, and its 
function is thought to play a role in bladder signaling during filling (Ikeda et al. 2007). As 
a control, Cx26 was detected in liver lysates, while absent in heart lysates from wild-type 
mice (Figure 2.9A). Cx26 generally resolves in SDS-PAGE at ~20 kD, with a dimer 
species appearing in liver at —35-37 kD. Immunoblotting of Cx26 in lysates from G60S 
and I DOT mice and their wild-type littermates revealed low levels of Cx26 in bladder 
samples of all mice (Figure 2.9A). Densitometry analysis revealed similar Cx26 bladder 
levels of G60S and I DOT mice compared to their wild-type littermates (Figure 2.9B,C).
Figure 2.7 G60S mouse bladders have altered Cx43 distribution in the lamina propria, 
while I130T bladders display similar Cx43 distribution as wild-type littermates. Cryo- 
embedded bladder samples were sectioned and labeled for Cx43. Cx43 was localized to the 
lamina propria of the G60S, I130T and their wild-type littermate mouse bladders (A, B). G60S 
mouse bladders display a more diffuse Cx43 distribution (arrows), as opposed to the punctate 
distribution (arrowheads) seen in wild-type littermates (A). However, I DOT mouse bladders 
display a similar punctate Cx43 distribution (arrowheads) pattern seen in wild-type littermates 




Figure 2.8 G60S and I130T mice and their wild-type littermates display distinct Cx43 
detrusor localizations. Cryo-embedded bladder samples were sectioned and labeled for Cx43. 
Cx43 is predominantly localized to the connective tissue surrounding smooth muscle bundles in 
G60S, I130T and their wild-type littermate mouse bladders (A, B). Cx43 displays punctate 
structures (arrowheads) in G60S (A), I130T (B) and wild-type littermates. However, bladders 
from G60S mice appear to have a more diffuse Cx43 distribution profile (arrows), similar to the 
lamina propria, compared to wild-type littermates. Red = Cx43, Green = F-actin. Blue = Hoechst 








Figure 2.9 G60S and I130T mouse bladders have similar Cx26 levels as wild-type 
littermates. Cx26 generally resolves at ~21 kD with a dimer at ~37 kD as seen in liver lysates 
(A). G60S, I130T and wild-type littermate bladders were all positive for Cx26 expression (A). 
Total Cx26 expression was similar in I130T and G60S mice and their wild-type littermates (B, 
C). A non-specific band located at ~32-34kD was noted. Bars represent means ± s.e.m (B-E). N
= 5 (I DOT) and 6 (G60S)
Figure 2.9
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Immunoblotting also revealed a nonspecific bands located at ~32-34kD in lysates from 
all bladder sample. Although the band was present in only the bladder samples, it is 
unclear as to what this band represents and therefore was not included in the densitometry 
analysis.
2.3.9 Cx26 is localized to an intracellular compartment in the basal urothelium of
mutant and wild-type littermates
Immunoblotting revealed that Cx26 levels remain similar between wild-type and 
Cx43 mutant mice; however, it is unclear if Cx26 localization and/or distribution is 
altered, which could suggest the mutant mice have a bladder defect. As a positive control 
Cx26 was clear detected at the cell-cell apposition of liver hepatocytes (not shown). 
Immunofluorescence revealed that Cx26 localization was similar in G60S and I130T and 
their wild-type littermates (Figure 2.10A-D) and predominantly localized to the basal 
urothelium. Surprisingly, Cx26 was localized to intracellular locations and not, as 
expected, to intercellular boundaries.
Figure 2.10 Cx26 was localized to intracellular compartments of basal urothelial cells of 
mutant and wild-type mice. Cryo-embedded bladder samples were sectioned and labeled for 
Cx26. Cx26 displayed a strong basal urothelium expression and a unique localization pattern to 
an intracellular compartment in all mice (A, B). Uro = Urothelium. LP = Lamina Propria. Red = 







GJIC is an important bladder feature thought to contribute to normal bladder 
function by allowing for a coordinated contraction and ejection of urine from the bladder 
lumen (Fry et al. 2007, Hashitani et al. 2004, Neuhaus et al. 2007, Sui et al. 2002). Cx43 
is the most prevalent connexin expressed in the bladder as it is found in both the lamina 
propria and detrusor layer (Fry et al. 2007, Neuhaus et al. 2005, Sui et al. 2002, Sui et al. 
2003, Wang et al. 2006). Therefore, any alteration in Cx43 function, such as that found in 
ODDD patients, where one copy of the gene encoding Cx43 carries a loss-of-function 
mutation may affect GJIC and ultimately bladder function. Bladder impairments in 
ODDD patients generally do not manifest until the second half of an individual’s life 
(Goepel et al. 2010, Loddenkemper et al. 2002), long after the original diagnosis of 
ODDD. However, many ODDD patients suffering from bladder defects are in their teens 
or early twenties, which is extremely rare for the general population (Pazenkas et al. 
2009). Thus suggesting that ODDD patients may have an increased propensity to 
developing a bladder defect in comparison to the general population. Therefore, it 
remains possible that the number of ODDD patients with bladder impairment is under­
reported, as symptoms may not be archived as an ODDD-associated disease. It also 
remains possible that only some ODDD-associated mutations result in bladder 
impairments and that the location of the mutation, the resulting amino acid change and 
the patient’s genetic background all contribute to the development of bladder impairment. 
Adding to the complexity, it is unclear if bladder abnormalities reported by ODDD 
patients are due to neurogenic or myogenic defects (Christ et al. 2003, Haefliger et al. 
2002). In the present study we found no difference in the localization, dye transfer or
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ATP release between Cx43 mutants which have been linked to bladder impairments 
(D3N and G143S) and those which have not (G2V and I130T). We also assessed the 
connexin status in the bladders of two genetically distinct Cx43 mutant mouse models of 
ODDD (G60S and I DOT mice), and found the both mutant mouse lines have reduced 
levels of phosphorylated Cx43 compared to their wild-type littermates controls. 
Collectively, these results suggest that any Cx43 gene mutation, regardless of the 
mutation site, may contribute to the development of incontinence or other bladder 
abnormalities. Furthermore, mice harbouring systemic Cx43 mutants have an anatomical 
and histological normal bladder even though Cx43 may be spatially disorganized and 
exist primarily as species that are incompletely phosphorylated.
2.4.1 Characterization of Cx43 mutants reveal no distinguishable difference
between bladder disease -associated and -unassociated Cx43 mutants
Previous studies investigating Cx43 mutants revealed that the majority of Cx43 
mutants maintain the ability to assemble into gap junction plaques at sites of cell to cell 
apposition; as well, all mutants studied acted as dominant-negatives to the gap junction 
channel function of co-expressed endogenous Cx43 (Dobrowolski et al. 2007, Gong et al. 
2007, McLachlan et al. 2005, Roscoe et al. 2005, Shibayama et al. 2005). The focus of 
our study was to determine if any differences exist between the bladder disease -  
associated (D3N and G143S) and -unassociated (G2V and I DOT) Cx43 mutants. The 
current information regarding the G2V mutant is limited to its original identification in a 
patient screen (de la Parra and Zenteno 2007). Our study is the first to report that the G2V 
mutant contains no apparent assembly defect in both Cx43-negative (HeLa) and Cx43-
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positive (NRK) cells. Furthermore, the G2V mutant exhibited loss-of-function channel 
activity, and was found to act as a dominant-negative to the gap junction channel function 
of co-expressed endogenous Cx43. These finding are in keeping with studies which 
revealed that Cx43 mutants D3N (Churko et al. 2011), I130T (Lai et al. 2006, Shibayama 
et al. 2005), and G143S (Dobrowolski et al. 2007) assembled into non-functional gap 
junction-like plaques and acted as dominant-negatives to co-expressed Cx43.
Cx43 proteins are also known to form hemichannels in the plasma membrane, 
which possess the ability to open and release ATP under specific mechanical and 
chemical stimuli, such as reduced extracellular calcium (Dobrowolski et al. 2007, Stout et 
al. 2002, Tong et al. 2007). One research group revealed that the G143S mutant has 
increased hemichannel activity when activated (Dobrowolski et al. 2007). Since, ATP is 
an important signaling molecule within the bladder (Apodaca 2004, Birder 2001, 
Cockayne et al. 2000) the potential gain-of-hemichannel function could theoretically 
contribute to a disease phenotype in the bladder. However, unlike Dobrowolski et al., 
(2007) we could not detect any G143S or I130T mutant gain-of-hemichannel function 
that would lead to ATP release. We have no immediate reasoning for these differences 
but speculate that it may be related to the sensitivity of our ATP release assays, as 
unexpectedly wild-type Cx43 did not significantly increase ATP release as previously 
shown (Dobrowolski et al. 2007, Stout et al. 2002, Tong et al. 2007). Two possible 
explanations exist to explain this discrepancy: Firstly, HeLa cells may be quite efficient 
at assembling cell surface hemichannels into gap junction channels, thus at any point in 
time the hemichannel content in HeLa cells that overexpress Cx43 may be quite low. 
Secondly, our cells may have been too confluent and therefore Cx43 was unable to form
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hemichannels, as it was directly sequestered into gap junction channels. Interestingly, one 
report has suggested that the interaction between the Cx43 intracellular loop and 
cytoplasmic tail is important in controlling hemichannel activity (Ponsaerts et al. 2010). 
Therefore, we speculate that the G143S and I130T mutants may disrupt this interaction, 
resulting in non-functional hemichannels. Nevertheless, we did detect a gain-of- 
hemichannel function when we expressed the amino terminus localized G2V and D3N 
mutants. This gain-of-hemichannel function was not evident when the mutants were 
tagged with GFP suggesting that the bulky GFP may be sterically hindering the function 
of the Cx43 mutants. The amino terminus is known for its role in voltage-dependent 
channel gating (Bukauskas and Peracchia 1997, Kyle et al. 2009), and therefore it is 
possible that these mutants disrupt voltage-gating, allowing the hemichannel to remain in 
a partially open configuration. It was interesting that none of the Cx43 mutants examined 
altered the hemichannel activity of endogenous Cx43, suggesting that the mutants were 
not acting as dominant-negatives to hemichannel function of wild-type Cx43.
Collectively, we found no consistent difference between the bladder disease -  
associated (D3N and G143S) and -unassociated (G2V and I DOT) Cx43 mutants in their 
intracellular localization, channel forming ability, ability to form hemichannels and 
ability to act as dominant-negatives on co-expressed endogenous Cx43. We speculate that 
the in vitro studies preformed may be insufficient to discriminate between bladder disease 
-associated and -unassociated Cx43 mutants, which led us to examine the connexin
status in the bladders of two mutant mouse lines that mimic ODDD.
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2.4.2 Characterization of Cx43 in the bladder of G60S and I130T mutant mice
Neurological defects are frequently found in ODDD patients, although they 
generally do not manifest until the second half of the patient’s life (Loddenkemper et al. 
2002). Bladder abnormalities have been reported in ~12% of ODDD patients and have, 
in a couple of cases, been linked to neurological defects; however, there is increasing 
evidence that suggests some bladder abnormalities are the result of myogenic defects 
(Christ et al. 2003, Haefliger et al. 2002). Many reports have localized Cx43 within the 
lamina propria and detrusor layers of the bladder and other studies have linked Cx43- 
based gap junctions to various bladder syndromes (Christ et al. 2003, Mori et al. 2005, 
Neuhaus et al. 2007, Sui et al. 2002). It therefore remains possible that ODDD mutants, 
which disrupt Cx43 function (Dobrowolski et al. 2007, Gong et al. 2007, McLachlan et 
al. 2005, Roscoe et al. 2005, Shibayama et al. 2005), may ultimately affect bladder 
function. In order to assess this possibility, we included in our study two Cx43 mutant 
mouse lines, G60S and I DOT, both of which have been shown to phenotypically 
resemble ODDD patients (Flenniken et al. 2005, Kalcheva et al. 2007, Langlois et al. 
2007, Toth et al. 2010), but it is unknown if they suffer from incontinence or any bladder 
abnormalities. Importantly, both mutant mice are predicted to possess a 1:1 ratio of 
mutant to wild-type Cx43, matching the phenotype of human ODDD patients. As well, 
the two mutant mouse lines were generated on different genetic backgrounds, more 
readily mimicking the diverse genetic background of ODDD patients. Previous studies 
have revealed that both mutant mouse lines have altered tissue function and/or 
development of the heart, bone, skin and teeth (Flenniken et al. 2005, Kalcheva et al. 
2007, Langlois et al. 2007, Toth et al. 2010); however, no studies have assessed the
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connexin status within the bladder. Here, we aimed to determine the connexin 
localization and expression profile, as possible indicators of altered bladder function.
2.4.3 Differential Cx43 phosphorylation and subsequent distribution may disrupt
bladder signaling and contractile stimulus propagation in mutant mice
Previous studies have localized Cx43 to the rat lamina propria and detrusor layers 
of the bladder (Fry et al. 2007, Neuhaus et al. 2005, Sui et al. 2002, Sui et al. 2003, Wang 
et al. 2006). One of the simplest indicators of an overactive bladder syndrome is to look 
for detrusor hypertrophy (Miyazato et al. 2009, Uvelius et al. 1984). First, assessment of 
wild-type and mutant mice revealed an anatomically similar bladder and no differences 
were observed in the appearance or thickness of the detrusor layer. Within the lamina 
propria, we found Cx43-positive staining in all mice localized to what was assumed to be 
fibroblasts and myofibroblasts, based on vimentin-positive staining (Neuhaus et al. 2007, 
Sui et al. 2002). Myofibroblasts, in particular, are important in forming a functional 
syncytium for the rapid transmission of chemical and electrical stimuli, required for 
normal bladder function (Fry et al. 2007, Sui et al. 2002, Wiseman et al. 2003). Cx43 in 
the detrusor is thought to mediate the propagation of action potentials from one smooth 
muscle bundle to the next, allowing for a uniform bladder contraction (Hashitani et al. 
2004). The results showed that while the wild-type and I130T mice displayed punctate 
gap junction-like structures, the G60S mutant mice displayed a more diffuse intracellular 
Cx43 expression profile in addition to several punctate structures. A similar diffuse 
localization profile of Cx43 was also observed within the detrusor layer of G60S mice, in 
which Cx43 has been localized to the border of smooth muscle bundles, as seen
previously (Hashitani et al. 2004, Wang et al. 2006). The more diffuse Cx43 expression 
profile seen in the G60S mice bladders is correlated with the reduction in the highly 
phosphorylated Cx43 species (PI and P2), known to be important in of gap junction 
plaque formation and GJIC (Koo et al. 1997, Solan and Lampe 2009). Interestingly, the 
I130T mice bladders also exhibited a reduction in the highly phosphorylated Cx43 
species, as well as reduced total Cx43 protein levels. Therefore, we conclude that in both 
mutant mouse lines Cx43 is not likely forming fully assembled gap junction plaques, 
which likely corresponds to non-functional gap junction channels in myofibroblasts and 
connected smooth muscle bundles, similar to that seen in other cell types (Flenniken et al. 
2005, Kalcheva et al. 2007, Lai et al. 2006, Manias et al. 2008, McLachlan et al. 2005, 
Shibayama et al. 2005).
Even though bladder abnormalities are most commonly linked to Cx43 increases 
(Christ et al. 2003, Imamura et al. 2009, Li et al. 2007, Mori et al. 2005), it remains 
possible that a reduction in Cx43 levels and/or a resulting decrease in GJIC may also alter 
bladder function. Reduced GJIC may alter electrical and chemical stimulus propagation 
within the bladder, resulting in incomplete bladder contractions, increased residual urine 
levels and ultimately increased urinary frequency in both mutant mouse lines. 
Collectively, if GJIC is required for normal bladder function, this would suggest that the 
G60S and I DOT mutants would possess the same propensity to develop a bladder 
phenotype. Additional behavioral studies are necessary to see if Cx43 mutant mice suffer 
from frequent urination and/ or bladder leakage.
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2.4.4 Cx26 unique basal urothelial expression profile may contribute to bladder
function
Even though our study revealed no Cx43 staining in the bladder urothelium, other 
groups have localized both Cx43 and Cx26 within this layer (Grossman et al. 1994, 
Haefliger et al. 2002). Therefore, as a result of Cx26 being localized to the urothelial 
layer as well (Gee et al. 2003, Grossman et al. 1994, Haefliger et al. 2002, Ikeda et al. 
2007), we speculated that Cx26 may be upregulated in the urothelium to compensate for 
the overall reduction of Cx43 in the lamina propria and detrusor layers through potential 
signaling cross-talk mechanisms. The function of Cx26 within the urothelium is still 
unknown although it is thought to play a role in signal transduction during bladder filling 
(Ikeda et al. 2007). Cx26 localization in the urothelium has been reported to be typically 
at sites of cell to cell apposition (Haefliger et al. 2002, Ikeda et al. 2007); however, one 
group has reported an intracellular profile of Cx26 expressed throughout the entire 
urothelium (Gee et al. 2003). Other reports have also indicated that Cx26 hemichannels 
can release ATP into the extracellular environment (Huckstepp et al. 2010, Majumder et 
al. 2010), which may alter bladder function. In our study, the levels of Cx26 were similar 
between mutant and control groups. Interestingly, Cx26 displayed a unique intracellular 
urothelium expression profile localized to only the basal urothelium, suggesting that few, 
if any, gap junction channels or hemichannels are formed in this cell layer. Nevertheless, 
we found no evidence that Cx26 was being upregulated to compensate for the proposed
loss-of-Cx43-function in the bladder.
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2.4.5 Conclusion
In this study, we found no difference in the localization, dye transfer or ATP 
release between bladder disease -associated (D3N and G143S) and -unassociated (G2V 
and I DOT) Cx43 mutants. Thus, the reason why only some ODDD patients suffer from 
incontinence is not likely linked to how a specific mutation changes the channel function 
but rather rooted in other mechanisms. It is possible that other defects exist in the bladder 
-associated mutants that have not been revealed in the present study such as alterations in 
their ability to interact with members of the gap junction proteome (Laird 2010), or 
alternatively, any ODDD-linked Cx43 mutant may have the capacity to contribute to the 
onset of bladder disease that is governed by additional genetic factors and the aging 
process. Future studies will require additional mutant mice that harbor specific mutations 
that have strong linkages to patients with bladder abnormalities.
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CHAPTER 3
Characteristics and Functions of Connexin43 Recessive Mutants linked
to Oculodentodigital Dysplasia
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A rare developmental disease known as oculodentodigital dysplasia (ODDD) 
generally manifests as a result of one of over sixty known autosomal-dominant mutations 
in the gene GJA1, which encodes for connexin43 (Cx43). Recently, two autosomal- 
recessive mutations, resulting in the Cx43 mutants R76H and R33X (X represents a 
nonsense mutation resulting in a stop codon), have been reported in a genetic screen of 
patients suspected of having ODDD, but the characteristics of these mutants and how 
they cause disease only in the homozygous state remains unknown. To investigate the 
characteristics of the R76H and R33X recessive mutant we expressed both mutants in 
reference cell lines that lack or contain endogenous Cx43. Immunofluorescence revealed 
that only the R76H mutant exhibited the ability to form gap junction plaques at sites of 
cell to cell apposition, while the R33X mutant displayed a more diffuse intracellular 
expression profile. Lucifer yellow dye transfer studies revealed that the R76H mutant 
retained some residual gap junction channel function, which was not seen in the R33X 
mutant. In addition, the expression of either mutant did not affect the ability of cells to 
release ATP. We proposed that the R76H and R33X mutants are less potent at impairing 
gap junctional intercellular communication in the heterozygous state than other well 
studied autosomal-dominant mutants allowing heterozygous carriers of this mutation to 
be disease free. The residual gap junction channel forming ability of the R76H mutant 
and the inability of the R33X to oligomerize into gap junction channels is predicted to 
allow for carriers of this gene mutation to be disease-free with disease only manifesting 
in cases where a patient harbors the mutation on both alleles.
Keywords: Connexin, Cx43, mutants, recessive, GJIC, hemichannel, homozygous
3.0 Abstract
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Gap junctions are specialized membrane channels that allow for the transfer of 
small molecules, ions, metabolites and second messengers between the cytoplasms of two 
connected cells (Alexander and Goldberg 2003, Musil and Goodenough 1990). Gap 
junctions are produced as the result of an oligomerization of six connexin (Cx) proteins, 
forming a connexon, which is delivered to the plasma membrane (Goodenough et al. 
1996). A connexon can exist either as a singular unit within the plasma membrane, 
known as a hemichannel, or dock with a connexon of from an apposing cell forming a 
gap junction channel (Li et al. 1996, Musil and Goodenough 1990). There are 21 
members of the human connexin family, all of which share a similar membrane topology 
consisting of four transmembrane domains, two extracellular loops, an intracellular loop 
and cytoplasmically exposed amino and carboxyl termini (Sohl and Willecke 2004).
Connexins are temporally and spacially regulated in human physiology, and many 
cell types are known to express one or more connexin isoforms. As a result, various 
connexin hexamers can exist, resulting in channel selectivity unique to its connexin 
constituents (Brink et al. 1997, Falk 2000). Connexons and gap junction channels 
composed of one connexin are termed homomeric and homotypic respectively, whereas 
those composed of two or more distinct connexins are termed heteromeric and 
heterotypic, respectively (Rackauskas et al. 2010). Therefore, as a result of the ubiquitous 
use of gap junctional communication it becomes apparent that an alteration in a cells 
ability to communicate can produced a number of human pathologies (Cronier et al.
2009).
3.1 Introduction
Mutations in the gene encoding the almost ubiquitously expressed connexin,
Cx43, results in the rare autosomal-dominant disease called oculodentodigital dysplasia 
(ODDD). ODDD is characterized by several common clinical phenotypes such as 
syndactyly and camptodactyly of the digits, microdontia, enamel loss, ophthalmic defects 
and craniofacial abnormalities (Paznekas et al. 2003). To date, over 60 known mutations, 
spanning the Cx43 gene sequence, have been linked to ODDD (Paznekas et al. 2009).
The majority of the mutations associated with ODDD are autosomal-dominant and have 
been shown to reduce channel function and act as dominant-negatives to the function of 
co-expressed wild-type Cx43 (Gong et al. 2007, McLachlan et al. 2005, Roscoe et al. 
2005). However, recent clinical presentations and genetic screening have revealed two 
autosomal-recessive mutations linked to ODDD, corresponding to the Cx43 mutants 
R76H and R33X (Paznekas et al. 2003, Pizzuti et al. 2004, Richardson et al. 2006). The 
current information on these patients is very limited. Interestingly, recessive Cx43 
mutations provide a unique platform to study the function of Cx43 throughout various 
tissues and organs of the human body. Previous studies employing Cx43 knock-out mice 
revealed that Cx43 is required for normal tissue development and that the loss of Cx43 is 
lethal at birth (Reaume et al. 1995). In humans, the R33X autosomal recessive mutant, 
consisting of only the amino terminus and a partial fragment of the first transmembrane 
domain of Cx43 will not form gap junction channels, suggesting that these patients are 
essentially equivalent to a Cx43 knockout. Unlike knock-out mice, patients homozygous 
for the R33X mutant do survive past birth, although they display very severe clinical 
symptoms of ODDD including small deep set eyes, complete syndactyly, 
ophthalmological defects and dental abnormalities, (Richardson et al. 2006) and their life
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expectancy is expected to be short. However, the patients harbouring the autosomal 
recessive R76H mutant appeared to share similarities to the autosomal dominant ODDD 
patients including hypotrichosis and dental abnormalities (Pizzuti et al. 2004). This raises 
the possibility that the R76H mutant may have residual gap junction channel function, 
although this has yet to be tested.
In this study we assessed the localization and function of two autosomal recessive 
Cx43 mutants, R33X and R76H. Collectively, the information gained may provide 
insight into why patients harbouring the autosomal recessive R33X mutant may possess 




All cell culture components were purchased from Invitrogen (Burlington, ON), 
and Becton-Dickenson (BD, Franklin Lakes, NJ). Human cervical cancer (HeLa) and 
normal rat kidney (NRK) cells were cultured as previously reported (Jordan et al. 1999, 
Thomas et al. 2005). Human untagged and/or GFP-tagged Cx43 mutant R76H and R33X 
cDNA constructs were purchased from Norclone Biotech Industries (London, ON). 
Transient transfected cells were generated using Lipofectamine 2000 reagent (Invitrogen) 
as recommended by the manufacturer and as previously described (Roscoe et al. 2005) 
with the following changes. Transfections were performed using 5 pg of plasmid cDNA 
and 2 pL of Lipofectamine 2000 reagent. Untagged Cx43 mutants used in the 
microinjection dye transfer assays required a co-transfection with 1 pg DsRed plasmid 
cDNA to discriminate between transfected and non-transfected cells. For ATP release 
studies, HeLa and NRK cells were seeded in 12 well culture plates, containing one glass 




Transfected cells were fixed and immunolabeled as previously described (Roscoe 
et al. 2005). Briefly, cells grown on 12 mm glass coverslips were fixed for 15 minutes 
with precooled -20°C 80% methanol-20% acetone at 4°C. All antibodies were diluted in 
3% bovine serum albumin (BSA) (Sigma-Aldrich, St Louis, MO) and 0.02% Triton- 
XI00 in PBS. Cells expressing untagged or GFP-tagged R76H and R33X Cx43 mutants
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were incubated for one hour at room temperature with polyclonal rabbit anti-Cx43 
primary antibody (2 pg/ml; Sigma). Cells were washed several times with PBS and 
incubated for 1 hour at room temperature with anti-rabbit AlexaFluor 555 antibody (4 
pg/ml; Invitrogen). Hoechst 33342 nuclear stain (10 pg/ml; Molecular Probes, Eugene, 
OR) was applied for 5 minutes at room temperature followed by a 5 minute wash with 
ddH20. Labelled cells were imaged on a Zeiss LSM 510 Meta confocal microscope as 
previously described (Roscoe et al. 2005) and images were analyzed using a Zeiss LSM.
3.2.3 Microinjection Dye Transfer Assay.
HeLa or NRK cells clusters transiently expressing untagged or GFP-tagged Cx43, 
R76H, and R33X were selected for microinjection. For GFP tagged mutants, cell clusters 
with clear GFP signals in contacting cells were selected for microinjection. For untagged 
mutants, cell clusters expressing DsRed in contacting cells were selected for 
microinjection. A single transfected cell was pressure injected as previously described 
(Roscoe et al. 2005). Digital images were collected using a Lecia DM IRE2 inverted 
epifluorescence microscope with a charged coupled camera (Hamamstsu Photonics, 
Japan) using OpenLab software. If dye was successfully transferred to a GFP or RFP 
expressing cell contacting the microinjected cell, the test was recorded as a positive. A 
minimum of 50 microinjections were preformed for each mutant tested.
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3.2.4 ATP Release Assay
HeLa or NRK cells transiently transfected with cDNA encoding untagged or 
GFP-tagged Cx43, R76H and R33X were selected. ATP release assays were performed 
as described previously (Tong et al. 2007), with the following changes. Cells were 
washed and incubated in either HBSS (Invitrogen) containing calcium and magnesium or 
divalent-cation-free (DCF)-HBSS (Ca2+and Mg2+ were replaced by 2mM EGTA). 
Following a 15 minute incubation at 37°C, 10 pL of the incubation solution was mixed 
with 90 pL of the ATP Determination Kit (Invitrogen) reaction solution in a 96-well 
plate. Bioluminescence (at a wavelength of -560 nm) was measured using a luminometer 
(PerkinElmer, Waltham MA) and ATP concentrations were determined. To determine 
transfection efficiency, coverslips containing transfected cells were fixed, labeled and 
imaged for Cx43 as previously described (Roscoe et al. 2005). Four images per 
transfection were assessed and the transfection efficiency was recorded by an observer 
blinded to the treatment conditions.
3.2.5 Statistics
Microinjection and ATP release assay results were analyzed using a Student two- 
tailed independent sample t-test, with significance denoted by P<0.05. All results were 
analysed using GraphPad Prism 4.03 software, and are presented as mean ± standard
error.
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3.3.1 The Cx43 R76H mutant localized to sites of cell to cell appositions in HeLa 
and NRK cells
Cx43-negative HeLa cells and Cx43-positive NRK cell were transiently 
transfected with cDNA constructs encoding the autosomal recessive R76H and R33X 
Cx43 mutants. Immunofluorescence revealed that control wild-type GFP-tagged and 
untagged Cx43 expressed in HeLa (Figure 3.1 A) or NRK (Figure 3.IB) cells resulted in 
the formation of gap junction-like plaque structures at sites of cell to cell apposition. 
Similarly, the R76H mutant assembled into gap junction-like plaques at sites of cell to 
cell appositions in both HeLa (Figure 3.1 A) and NRK (Figure 3.1 B) cells. However, the 
mutant R33X failed to form any plaques and exhibited a homogenous cytoplasm and 
nuclear localization profile in both cell lines (Figure 3.1A,B). The R33X mutant was not 
stained with anti-Cx43 antibody (Figure 3.1 A) as the Cx43 antibody used was developed 
using an epitope from the carboxyl terminus, and thus would not be able to bind to the 33 
amino acid amino terminus fragment.
3.3.2 Gap junction channels formed from the R76H mutant are partially 
functional
To determine if the autosomal recessive mutants (R76H and R33X) formed 
functional channels, mutant expressing HeLa cells were microinjected with Lucifer 
yellow and dye transfer was assessed. The R76H mutant was found to exhibit a -20-35% 
higher incidence of dye transfer compared to untransfected HeLa cells (Figure 3.2A). 
These results suggest that the channels formed by the R76H mutant can form functional
3.3 Results
Figure 3.1 The R76H, but not the R33X, mutant forms gap junction-like plaques at sites of 
cell-cell appositions. HeLa and NRK cells were transfected with cDNA encoding Cx43, Cx43- 
GFP, R76H, R76H-GFP or R33X-GFP. The R76H mutant assembled into gap junction-like 
plaques (arrowheads) at sites of cell-cell appositions in both HeLa (A) and NRK (B) cells, while 
the R33X mutant displayed a cytoplasm and nuclear localization profile in both cell lines (A, B). 
Cells were immunolabeled for Cx43 (Red). Controls HeLa and HeLa-Cx43-GFP, NRK and 
NRK-Cx43-GFP are the same data set used in chapter 2, sections 2.3. Green = GFP, Blue = 




GFP Anti - Cx43 Merge GFP And - Cx43 Merge
Figure 3.1
Figure 3.2 The R76H Cx43 mutant can be assembled into gap junction channels and acts as 
a dominant-negative to the function of wild-type Cx43. HeLa and NRK cells expressing the 
Cx43 mutants were subjected to microinjection with Lucifer yellow and assessed for dye 
transfer. HeLa cells expressing the R76H or GFP-tagged R76H mutant exhibited a significant 
increase in the incidence of dye coupled cells while the R33X mutant expressing cells failed to 
pass Lucifer yellow (A). However, both recessive mutants acted as dominant-negatives to the 
gap junction function of endogenously expressed Cx43 (B). Controls HeLa, HeLa (Cx43-GFP), 
NRK and NRK (Cx43-GFP) are the same data set used in chapter 2, sections 2.3. Bars represent 
means ± s.e.m. *, a, b = (P<0.05). N = 5-6 replicate transfections
Figure 3.2
•̂ 1
channels, although maybe not to the same efficiency as wild-type Cx43. The R33X 
mutant did not form functional channels. Furthermore, both mutants reduced the 
incidence of dye transfer by in NRK cells -34-76% (Figure 2B), suggesting that these 
mutants can act as dominant-negatives to the function of co-expressed wild-type Cx43.
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3.3.3 The recessive mutants produced similar levels of ATP release as wild-type
HeLa and NRK cells
The ability of Cx43 mutants to regulate ATP release was assessed using a low 
calcium hemichannel release assay in HeLa cells and NRK cells. All cells exhibited an 
increase in ATP release when calcium levels were low as opposed to normal culture 
levels (Figure 3.3A,B). However neither recessive mutants or wild-type Cx43 resulted in 
an increase in ATP release in HeLa cells (Figure 3.3A). As well, when co-expressed with 
endogenous Cx43, all GFP-tagged Cx43 mutants resulted in similar levels of ATP release 
as compared to untransfected NRK cells (Figure 3.3B).
Figure 3.3 Recessive mutants R76H and R33X did not alter ATP release in HeLa or NRK 
cells. HeLa and NRK cells transfected with cDNA encoding Cx43-GFP, R76H-GFP, R33X-GFP 
were treated using HBSS with calcium (+Ca ) or without calcium (-Ca ) and assessed for 
extracellular ATP concentrations. HeLa cells expressing GFP-tagged Cx43 mutants resulted in 
similar extracellular ATP concentrations as untransfected HeLa and wild-type Cx43 expressing 
cells (A). As well, when co-expressed with wild-type Cx43 the all GFP-tagged Cx43 mutants 
resulted in similar extracellular ATP concentrations as untransfected NRK cells (B). Controls 
HeLa, HeLa (Cx43-GFP), NRK and NRK (Cx43-GFP) are the same data set used in sections 2.3. 












To date, all autosomal dominant Cx43 mutants examined exhibited a loss of gap 
junction channel function and acted as dominate-negatives on the channel function of 
endogenous Cx43 (Dobrowolski et al. 2007, Gong et al. 2007, McLachlan et al. 2005, 
Roscoe et al. 2005, Shibayama et al. 2005). However, recent clinical presentation and 
genetic studies have uncovered two recessive Cx43 mutants, R76H and R33X (Paznekas 
et al. 2003, Pizzuti et al. 2004, Richardson et al. 2006). In the present study, we examined 
the localization and GJIC differences between the two recessive Cx43 mutants, R76H 
and R33X. These differences suggest a possible explanation as to why patients 
homozygous for the R33X mutant have greater ODDD morbidity that includes small 
deep set eyes, completed syndactyly, severe ophthalmological defects and tooth 
abnormalities (Richardson et al. 2006), compared to the R76H harbouring patients which 
have classical ODDD symptoms plus hypotrichosis (Pizzuti et al. 2004).
3.4.1 Characterization of recessive Cx43 mutants revealed that the R76H mutant
contains residual channel function
Our study revealed that the GFP-tagged and untagged recessive R76H mutant, but 
not the R33X mutant, possesses the ability to form gap junction-like plaques at sites of 
cell to cell apposition in both Cx43 -positive (NRK) and -negative (HeLa) cells. The 
R33X mutant, consisting of only the amino terminus and part of the first transmembrane 
domain of Cx43, exhibited a diffuse intracellular expression profile. The fact that the 
R33X mutant did not assemble into gap junctions is not surprising as less than 10% of the 
entire Cx43 protein is encoded by this mutant. As predicted from it diffused intracellular
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localization, the R33X mutant also failed to form functional gap junction channels. Thus 
the R33X mutant might be considered a Cx43 knockout. Interestingly, our study revealed 
that the R76H mutant formed functional gap junction-like plaques at sites of cell-cell 
apposition. This mutation is localized to the second transmembrane domain of Cx43 
where an arginine (R) residue is substituted by a histidine (H) residue thus maintaining 
the positive charge at this amino acid site. Thus, the conservative nature of this missense 
mutation may serve to retain the channel function. The functional and non-functional 
channels produced by the R76H and R33X mutants, respectively, provide an explanation 
as to why patients harbouring the R76H mutants, as opposed to those harbouring the 
R33X mutant, appear to display less severe ODDD symptoms (Pizzuti et al. 2004, 
Richardson et al. 2006). Interestingly, both recessive mutants caused a reduction in the 
function of co-expressed endogenous Cx43 channels, although it is important to note that 
we are likely highly overexpressing the mutants in NRK cells and exceeding the 1:1 
Cx43 to mutant ratio expected to be found in ODDD patients. Nevertheless, the parents 
of the ODDD patients would both be expected to have reduced overall Cx43 function but 
the degree of channel function appears not to be sufficiently severe to cause ODDD 
(Richardson et al. 2006). Interestingly, in the heterozygous state these are the first Cx43 
mutants identified that appear to not cause disease and only cause disease when both 
alleles encode the mutation. In all cases of autosomal dominant disease, when the mutant 
is expressed in reference cells in the absence of endogenous Cx43, no functional channels 
form.
The residual gap junction channel function exhibited by the R76H mutant may 
suggest that this mutant is also capable of forming hemichannels. It is well documented
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that wild-type Cx43 hemichannels open and release ATP under reduced extracellular 
calcium (Dobrowolski et al. 2007, Stout et al. 2002, Tong et al. 2007). As well, one 
research group showed that the G143S, I31M and G138R autosomal dominant Cx43 
mutants have increased hemichannel activity suggesting that these mutants have a gain- 
of-hemichannel function (Dobrowolski et al. 2007). However, neither the R33X or R76H 
recessive mutants exhibited gain-of-hemichannel function or acted as dominant-negatives 
to the hemichannel function of co-expressed endogenous Cx43.
3.4.2 Conclusion
Collectively, we found the recessive R76H mutant contains residual gap junction 
channel function which is unique from any other Cx43 mutant studied to date. We also 
found that the R33X mutant does not form gap junction-like structures or functional gap 
junction channels. Interestingly, parents of these ODDD patients do not display any 
ODDD symptoms despite harbouring a single copy of the Cx43 mutation, similar to the 
autosomal dominant patient population. Therefore, it appears that the residual function of 
the R76H mutant, and possibly the inability of the R33X mutants to oligomerize with 
wild-type Cx43 may enable heterozygotes of recessive mutants to be disease-free. The 
findings presented here also provide plausible explanations as to why patients harbouring 
the R76H mutant have less morbidity than patients harbouring R33X mutants. Both 
mutants represent unique opportunities to study the importance of Cx43 in development, 
as well as normal tissue function.
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4.1.1 Chapter 1 - Objective #1: Characterize the localization and function of 
bladder disease- associated (D3N and G143S) and unassociated (G2V and 
I130T) Cx43 mutants when expressed in reference cell models.
Previous studies have investigated the localization and functional status of the 
Cx43 mutants I130T and G143S (Dobrowolski et al. 2007, Lai et al. 2006, Shibayama et 
al. 2005); however the Cx43 mutants G2V and D3N were not previously studied. Our 
study was the first to compare and contrast the localization of function of bladder disease 
-associated (D3N and G143S) and -unassociated (G2V and I130T) Cx43 mutants linked 
to ODDD. All mutants formed non-functional gap junction plaque-like structures at sites 
of cell to cell apposition and acted as dominant-negatives to the function of co-expressed 
endogenous Cx43. Interestingly, the G2V and D3N mutants did exhibit a gain-of- 
hemichannel function, as assessed by ATP release, but no change in ATP release was 
found when cells expressed either the G143S or I130T mutants. Therefore, we found no 
discemable difference in the localization, gap junction channel function as assessed by 
dye transfer or hemichannel ATP release between bladder disease -associated and -  
unassociated Cx43 mutants.
4.1.2 Chapter 1 -  Objective # 2 : Determine the expression and distribution of Cx43 
and Cx26 in the bladder of G60S and I130T Cx43 mutant mice and their 
control littermates.
To our knowledge this study is the first to localize Cx43 and Cx26 proteins in the 
mouse bladder, as previous studies have focused on bladders from either rats or humans
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(Imamura et al. 2009, Kuhn et al. 2008b, Miyazato et al. 2009, Neuhaus et al. 2002a, 
Zhang et al. 2008). Our study employed two genetically different heterozygous mutant 
mouse models harbouring Cx43 mutants G60S and I DOT, which phenotypically 
resemble ODDD patients (Flenniken et al. 2005, Kalcheva et al. 2007). In vitro studies 
have previously shown that the G60S and I DOT mutants form non-functional gap 
junction plaques at sites of cell to cell apposition, therefore disrupting various organ 
development and normal function (Flenniken et al. 2005, Kalcheva et al. 2007, 
McLachlan et al. 2005, Shibayama et al. 2005, Toth et al. 2010). We found that Cx43 is 
expressed in both the lamina propria and detrusor layers of all wild-type and mutant 
mice. While in both mutant mouse lines Cx43 was localized to punctate structures 
indicative of gap junctions, in G60S mice, Cx43 also appeared more diffuse and 
intracellular. Nevertheless, both mutant mouse lines exhibited a reduction in the most 
highly phosphorylated Cx43 species which is known to be important in plaque formation 
and GJIC (Koo et al. 1997, Solan and Lampe 2009). As well, Cx26, which was localized 
to the basal urothelial layer in a unique intracellular distribution, was similar in all wild- 
type and mutant mice, suggesting that Cx26 expression did not act to compensate for 
perturbed Cx43 function. Therefore, if Cx43 is required for normal bladder function, and 
if the G60S and I DOT mutants are non-functional (McLachlan et al. 2005, Shibayama et 
al. 2005), the mutant mice may possess a bladder phenotype similar to that reported by 
ODDD patients.
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4.1.3 Chapter 2 -  Objective #1: Characterize the localization and function of two 
recessive Cx43 mutants (R33X and R76H) when expressed in reference cell 
models.
The current knowledge regarding Cx43 recessive mutants R76H and R33X is 
restricted to their original identification and documentation of the clinical symptoms 
expressed by the patients harbouring these mutants. Our study is the first to assess the 
localization, gap junction channel and hemichannel function of these mutants. While the 
R76H mutant formed plaques at sites of cell to cell appositions similar to wild-type Cx43, 
the R33X mutant displayed a more diffuse intracellular expression pattern. Interestingly, 
the R76H mutant contained residual gap junction channel function not seen by the R33X 
mutant or other autosomal dominant Cx43 mutants (Dobrowolski et al. 2007, Gong et al. 
2007, McLachlan et al. 2005, Roscoe et al. 2005, Shibayama et al. 2005). Interestingly, 
both recessive mutants acted as dominate-negatives to the function of co-expressed 
endogenous Cx43, a situation which partially mimics the genotype of the heterozygous 
parents of these patients. This latter result was unexpected as heterozygous carriers of 
these recessive mutants are disease-free. This discrepancy may be attributed to the 
extensive overexpression of the mutants in relationship to the endogenous Cx43. 
Importantly, both mutants did not affect ATP release in Cx43 -negative and -positive 
cells. These results provide clues as to why patients homozygous for the R76H mutant 
display classical ODDD symptoms similar to patients homozygous for autosomal- 
dominant mutants such as hypotrichosis and dental abnormalities (Pizzuti et al. 2004), 
while patients harbouring the R33X mutants have more extensive morbidities including:
small deep set eyes, complete syndactyly, ophthalmological defects and dental 
abnormalities (Richardson et al. 2006).
4.2 Contribution of Research
4.2.1 ODDD Patients and Bladder Abnormalities
Our study showed no molecular or Cx43 channel differences between disease -  
associated (D3N and G143S) and -unassociated (G2V and I130T) Cx43 mutants. Thus, 
we propose that patients harbouring any Cx43 mutant could exhibit a bladder defect 
depending upon the genetic background of the patient, age, or presence of additional 
disease burden. Similar to the normal population, bladder abnormalities generally do not 
manifest in ODDD patients until the second half of the patient’s life (Loddenkemper et 
al. 2002). However, as Cx43 seems to play a significant role in bladder function (Fry et 
al. 2007, Hashitani et al. 2004, Neuhaus et al. 2007, Sui et al. 2002), it may be possible 
that ODDD patients are more susceptible to developing bladder abnormalities and/or may 
develop them earlier in life compared to the general population. Interestingly, a small 
population of ODDD patient that have been diagnosed with bladder abnormality are in 
their teen and early twenties (Paznekas et al. 2009), which is extremely rare for the 
normal population. Currently, the percentage of bladder defects that are linked to ODDD 
patients is lower than the percentage of the general population documented with bladder 
defects (Abrams et al. 2003, Paznekas et al. 2009). However, we propose that the number 
of ODDD patients suffering from bladder defects may be larger than reported, as early 
diagnosis of bladder defects may be impossible in younger ODDD patients. Similar to the 
general population ODDD patients are dependent on diapers during their first several
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years. Therefore, bladder defects experienced by ODDD patients may not be linked back 
to the original diagnosis of ODDD, which generally occurs early in a patients life.
4.2.2 Recessive R76H Mutant Retains Residual Gap Junction Channel Function
Our results revealed differences in the localization and functional characteristics 
of the two autosomal-recessive Cx43 mutants, R76H and R33X. Interestingly, the R76H 
mutant forms gap junction channels that retain residual function, a characteristic not seen 
in the R33X mutant or any autosomal-dominant Cx43 mutant (Gong et al. 2007, 
McLachlan et al. 2005, Roscoe et al. 2005). The fact that the homozygous autosomal 
recessive R76H mutant retain residual channel function similar to heterozygous 
autosomal dominant mutants (Gong et al. 2007, McLachlan et al. 2005, Roscoe et al. 
2005) suggests a possible explanation as to why patients harbouring the R76H mutant 
display ODDD symptoms similar to patients harbouring autosomal dominant mutants. As 
well, it appears that the R76H mutant may disrupt the function of endogenous Cx43; 
however, the residual function of the R76H mutant may allow for heterozygous carriers 
of this mutation to maintain sufficient GJIC and remain disease free. Similarly, 
heterozygous carriers of the recessive R33X mutant are also disease free. The R33X 
mutant, which consists of only the amino terminus and a part of the first transmembrane 
domain may not be able to oligomerize with wild-type Cx43, thus not affected the 
channel. Interestingly, previous studies on Cx43 knock-out mice revealed that loss of 
Cx43 is lethal at birth while heterozygous mice are relatively normal (Reaume et al.
1995). Thus, the homozygous R33X mutant patients are essentially human Cx43-knock-
outs. The reason why R33X patients survive remains unknown but may be rooted in a 
compensatory action of other connexin proteins.
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4.3 Future Studies
4.3.1 Determine if Cx43 mutant mice possess a bladder phenotype.
The bladders of G60S and I DOT mice exhibit Cx43 intracellular distribution and 
reduction in highly phosphorylated Cx43 species. This information along with the in vitro 
loss-of-channel function assays of the same Cx43 mutants may suggest that the mutant 
mice may possess a bladder phenotype similar to that reported by ODDD patients. 
Therefore, future research should be directed toward determining if the Cx43 mutant 
mice possess a bladder phenotype by analyzing bladder cystometry and smooth muscle 
strip contractions (Imamura et al. 2009, Kim et al. 2010, Lee et al. 2011, Vahabi et al. 
2011, Zhang et al. 2011). Information obtained from these assays would provide insight 
into urinary frequency, pressure, urine output and smooth muscle contraction strength 
and shed insights into whether the bladders from mutant mice have any organ-based 
functional defects.
Interestingly, even though Cx43 appears to be important in the normal function of 
the bladder (Fry et al. 2007, Neuhaus et al. 2005, Sui et al. 2002, Sui et al. 2003, Wang et 
al. 2006), not all ODDD patients have been reported to carry bladder abnormalities. It 
remains possible that the specific mutations harbored by an ODDD patients is not critical 
for the onset of incontinence, but rather the issue relates extensively to the age of the 
patient and their specific genetic background. To assess this question further it would be 
beneficial to generate a mutant mouse line that harbors one of the bladder associated
mutants (D3N or G143S) used in the current study. As well as studying the mouse at 
difference age points, including infant, middle aged and elderly mice.
4.3.2 Use primary cultured smooth muscle and urothelial cells to assess the
channel activity in mutant and wild-type mice
Analyzing Cx43 mutants in reference cell lines is an excellent start to 
understanding how mutants function. However, to truly understand how a protein 
functions, it is important to look at its endogenous expression in primary cell types that 
are known to express the protein. The urothelium, lamina propria and detrusor layers of 
the bladder are known to express Cx43 (Grossman et al. 1994, Haefliger et al. 2002, 
Hashitani et al. 2004, John et al. 2003b, Sui et al. 2003, Wang et al. 2006), and therefore 
represent excellent models for studying endogenous Cx43 function. It is possible to 
produce primary cultures of the urothelium and detrusor layers of the bladder from Cx43 
mutants mice (Boselli et al. 2002, Galvin et al. 2004, Neuhaus et al. 2002b, Tyagi et al. 
2006), which can subsequently be use to study the gap junction channel or hemichannel 
activity via dye transfer, ATP release, dual-whole cell patch clamp and Ca2+ wave 
propagations (Neuhaus et al. 2002b). The information obtained about endogenous 
connexin status and function may reveal more pertinent information pertaining to the 





Collectively, this study has revealed several unique findings, previously unknown 
in the field of gap junctions. First, with respect to the bladder, it appears that the specific 
mutation harbored by an ODDD patient on its own may not be important in the 
manifestation of a bladder defect. Bladder abnormalities may be the result of multiple 
genetic factors associated with ODDD or the aging process itself. Although the current 
information suggests that ODDD patients are less susceptible as the general population to 
develop bladder defects (Abrams et al. 2003, Paznekas et al. 2009), more thorough record 
keeping of ODDD patients is required to determine this definitively. Second, as seen with 
the recessive R76H mutant, it appears as though some mutants retain residual gap 
junction channel function. Therefore, the varied functional status of different Cx43 
mutants may be an indicator of why ODDD patients do not all display the same 
symptoms. Further inquiry into both bladder-associated and recessive mutants is 
necessary to identify the molecular mechanisms that subsequently result in the symptoms 
displayed by patients harboring the associated mutants.
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